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 Epilepsy is a disorder of the brain characterised by an enduring predisposition to 
generate epileptic seizures and by the neurobiological, cognitive, psychological, and 
social consequences of this condition. Epilepsy is defined as a disease with either 
recurrent unprovoked seizures (ie, two or more unprovoked seizures occurring atleast 24 
hours apart) or a heightened tendency towards reccurent unprovoked seizures (ie, single 
seizure accompanied by evidence from clinical electroencephalography or neuro imaging 
tests that a heightened risk (at least 60%) exist for furture seizures over the next 10 





 Intractable epilepsy or drug-resistant epilepsy is defined as failure of adequate 
trials of two tolerated, appropriately chosen and used antiepileptic drug schedules 
(whether as monotherapies or in combination) to achieve sustained seizure freedom. This 
definition can be further refined when new evidence emerges. (ILAE, 2010) 
2
. Epilepsy 
is reported to affect approximately 3 million Americans and 50 million people around the 
world
210
. People with epilepsy suffer from brain damage resulting in a neurological 
deficit. Further, it leads to changes in social, occupational and behavioural aspects of 
individuals who have epilepsy causing devastating economic consequences. All the more 
it is evident that these consequences are significant in patients with intractable epilepsy. 
 
1.2. Prevalence and incidence of intractable epilepsy 
 In India, the prevalence of epilepsy is reported to be around 5.35/1000 estimated 
by the meta-analysis of 20 Indian published and unpublished studies 
3
.  Prevalence 
estimates are reported to be more in rural areas (5.47) than urban areas (5.11) also 
3 
  
epilepsy is more in men (5.88) than women (5.11) per 1000 population
3
. Most of the 
studies carried out for prevalence studies were based on door to door survey, random 
survey, screening instruments, and World Health Organization protocol
4
. In western 
countries prevalence of intractable epilepsy in adults was reported to be 5.4 per 1000 
population 
5
 which is comparable to that of the present population.  Despite the influx of 
new antiepileptic drugs over the past 10 years the incidence of intractable epilepsy is 




 There are several studies in western population to address the prevalence of 
intractable epilepsy. Due to the discrepancies in the terminologies (drug resistant 
epilepsy, intractable epilepsy, etc) and criteria for subject selection comparison between 
the prevalence of intractable epilepsy across various studies was difficult. Recently the 
prevalence of intractable epilepsy was reported by two studies in Italy 
7
 and Singapore 
8
 
using drug-resistant epilepsy criteria (ILAE, 2010).    In India, there are no such studies 
available using drug-resistant epilepsy criteria (ILAE, 2010). The prevalence of 
intractable epilepsy was reported to be ranging from 20 to 30% among patients with 
epilepsy in South India 
9
, but the actual studies estimating the prevalence of intractable 




1.3. Predictors of intractable epilepsy 
 There are various predictors of intractable seizures in India as reported by 
Tripathi et al among 200 patients. On univariate analysis they observed age of onset of 
seizure before fourteen years, partial seizures, presence of neurological deficits, perinatal 
insult, delayed milestones, history of CNS infection, febrile seizures, high initial seizure 
frequency of more than one per month, non-response to first antiepileptic drug and 
abnormal brain imaging as predictors for intractable epilepsy. On multivariate analysis, 
4 
  
significant predictors reported were radiological evidence of structural cerebral 
abnormality, non-response to first AED, delayed milestones, high initial seizure 
frequency of more than one per month, partial seizure type, febrile seizures and age of 
onset before fourteen years 
11
. In western countries, high frequency of seizure, neonatal 
seizure, birth injury, epileptic encephalopathy, early breakthrough seizure, neonatal 
status epilepsy as a first attack, structural damage due to birth trauma, neuronal migration 




1.4. Types of seizures and its clinical characteristics 
 International League Against Epilepsy (ILAE) have appointed a Task Force to 
formulate a consensus on the definition of drug resistant epilepsy and have classified into 
two hierarchy levels. Level 1 provides a general scheme to categorise response to each 
therapeutic intervention. Level 2 provides a core definition of drug resistant epilepsy 
using a set of essential criteria based on the categorization of response (from Level 1) to 




 Berg et al (2010) have modified the concepts, terminologies, and approaches in 
classification and terminology in epilepsy at International League against Epilepsy 
(ILAE) Commission 
13
. Epilepsy is classified as generalised seizures, focal seizures or 
Unknown as to whether focal, generalised, or depending on context. Generalised seizures 




1.4.1. Focal seizure 
 Focal seizure or partial seizures can present with many different forms. It 
depends on which area of the cortex is involved and how it spreads to other areas of the 






1.4.1.1. Simple partial seizure 
 Simple partial seizures (SPS) are focal seizures without the involvement of 
consciousness. Clinical characteristic of SPS includes the clonic activity of one hand or 
leg. It can spread to the other motor areas of the motor strip. This is called as Jacksonian 
seizures. After the seizures, post-ictal weakness (Todd paralysis) may occur for few 
minutes to hours. 
 
Clinical symptoms of SPS include: 
 Epilepsia partialis continua is a continuous focal motor seizure confined to 
particular body part usually clonic movements present for many days without 
alteration in the level of consciousness.  
 Motor speech arrest or vocalisation –arise from language area. Versive seizure-
dorsolateral frontal cortex (frontal eye feels). Clonic seizures arise from the 
supplementary motor area. In addition, the asymmetric posturing of the 
contralateral arm, externally rotated, abducted, elevated and turning of head 
contralaterally could also occur. 
 Simple partial seizures can also have autonomic symptoms like vomiting, 
sweating, piloerection, pupillary dilatation, pallor, flushing, borborygmi and 
incontinence of urine. 
 Simple partial seizure with somatosensory symptoms – seizures arise from 
postcentral gyrus will present as focal paresthesias, numbness, warmth and 
electrical shock-like sensation. It may spread like Jacksonian presentation. It also 
arises from a secondary sensory area that lies above the Sylvian fissure anterior to 
the precentral gyrus. It is characterised by the more widespread involvement of 
the sensation (contralateral, ipsilateral and bilateral involvement) 
 Sensory seizures-originates from the supplementary sensory area which is just 
6 
  
posterior to the supplementary motor area. Tingling, the desire for movement, 
feeling stiff, pulling, pulsing and heaviness also can occur. Sensory seizures arise 
from insular cortex presenting as symptoms involving nasopharyngeal, laryngeal 
regions such as paresthesias, warmth, tightening at throat or sense of 
strangulation and suffocation are also reported. 
 Special sensory symptoms include visual, auditory, gustatory, olfactory and 
vertiginous attack can be due to simple partial seizures. Each symptom may arise 
from the corresponding area of the cortex. Visual symptoms from primary or 
association visual cortex. Auditory symptoms arise from Heschl’s gyrus. 
Olfactory seizures originate from uncinate gyrus or medial temporal region. 
Gustatory sensation originates from temporal lobe insula and parietal operculum. 
Vertiginous symptoms originate from the lateral temporal region. A disturbance 
of higher cortical function in the form of psychic symptoms can present as a 
simple partial seizure. Dysphasic symptoms presenting as expressive or receptive 
language dysfunction, repetition of words or phrase is called epileptic palilalia.  
Dysmnesic symptoms such as memory distortion may be a form of simple partial 
seizure.  
 
1.4.1.2. Complex partial seizure (temporal and extratemporal) 
 Complex partial seizures (CPS) are defined as partial seizures with impairment of 
consciousness. They may present as SPS that may be an aura, and progress to complex 
partial seizures with the manifestation of CPS. Patients may develop complex partial 
seizures from early childhood to any point of time in human life. Genetic factor and 
congenital anomalies cause early onset of CPS. Acquired anomalies like stroke, 
neurodegenerative disorders can cause CPS at an older age. Trauma, infections can give 
7 
  




 Usually, CPS arises from frontal lobe or temporal lobes and rarely from occipital 
and parietal lobe. They can be further divided into temporal lobe epilepsy (TLE) or 
extratemporal lobe epilepsy. Temporal lobe epilepsy is the commonest form of focal 
epilepsy which may be of two types: 1) medial temporal lobe epilepsy and 2) lateral 
temporal (neocortical) epilepsy.  
 
 Clinical features of CPS may have different forms. It depends on which area of 
cerebral cortex is involved in the onset and propagation of the electrical discharge to the 
other areas of cerebral cortex. The patient may have motor, autonomic, somatosensory, 
special sensory or psychic symptoms. It may be an aura that will reveal the location of 
the seizure onset zone. 
 
Following auras may be partial epilepsy or initial manifestation of CPS: 
 Déjà vu - An illusion of a familiar memory 
 Jamais vu  - a familiar visual experience becomes unfamiliar 
 Déjà entendu - an auditory illusion of something familiar 
 Jamais entendu -  a familiar auditory experience becomes unfamiliar 
 Autoscopy - seeing oneself in external space as if the mind has left the body 
 Depersonalization - a feeling of unreality in one's sense of self, feeling as if in a 
dream or watching oneself act. 
 Macropsia/micropsia  - objects appear larger  or smaller than usual 




1.4.1.3. Temporal lobe epilepsy 
 Clinical feature of medial temporal lobe epilepsy is one of the very well known 
types of epilepsy described in the literature. Usually, occurs in adolescence or early 
adulthood. History of prolonged febrile seizures 
16 
may be involved in hippocampal 
sclerosis (HS) which is the cause for mesial temporal lobe epilepsy (TLE). Atrophy and 
gliosis of the hippocampus will be the marker for hippocampal sclerosis. The other 
causes for medial temporal lobe epilepsy are cavernous hemangiomas, gliosis and 
encephalomalacia secondary to past trauma/ injury, inflammation and infarction. 
Sometimes tumors such as Dysembryonic neuroepithelial tumors can cause medial TLE.  
 
The temporal lobe epilepsy is divided into two:  
 
1. lateral temporal lobe epilepsy (Neocortical) 
2. Medial temporal lobe epilepsy 
 
 Familial forms of medial TLE are usually responding to the drugs, the imaging 
studies will be normal, exact genetic mutation is not known. Lateral or neocortical TLE- 
less common than Medial TLE and less well defined. The symptomatology associated 
with LTLE is varying and it depends on the location of the seizure onset. Medial TLE 
can present with auras which include psychic sensations, gastric sensation, fear or 
olfactory symptoms.  
 
 In Medial Temporal lobe epilepsy, loss of consciousness happens immediately 
after aura. The oral and manual automatisms with mild unawareness are seen in patients 
with dominant temporal lobe seizures, but in cases of non-dominant temporal lobe 
seizures, manual automatisms with intact awareness are seen. Dystonic limb posturing is 
the sign of seizure onset from medial temporal lobe contralateral to the dystonic limb. In 
non-dominant temporal lobe seizure, ictal spitting, vomiting, and urinary urge are seen. 
9 
  
The seizure lasts for 60-90 seconds followed by confusion or disorientation, especially in 
dominant temporal lobe seizures.  Postictally language dysfunctions are also seen in 
dominant temporal lobe seizures. Medial temporal lobe seizures rarely end in secondary 
generalization, but it is common in the neocortical temporal lobe or extratemporal lobe 
epilepsy. There are several clinical features helps to localize the temporal lobe focus 
irrespective of the dominance. They are post-ictal nose wiping, ictal unilateral eye 
blinking and piloerection. The hand that wipes the nose first after the seizure is typically 
ipsilateral to the seizure focus. Preserved awareness and minimal post-ictal symptoms 
always delay the clinicians to make a diagnosis of non-dominant temporal lobe seizures. 
The patient may not be aware of the seizures because the symptoms are trivial.  
 
 The onset of a seizure in these areas will give rise to the specific aura, ictal 
manifestations, and post-ictal automatism. The latent and silent periods implies the 
progressive course of temporal lobe epilepsy which involves the cognitive functions of 
the brain, such as memory and intelligence impairment 
17,18
.  The clinical features of 
temporal lobe epilepsy can be categorized into subjective and objective type.  
 
Subjective features of TLE & stages of presentation 
1. Aura - 9% of patients with temporal lobe epilepsy will have an aura. Aura may be 
of the psychic, perceptual and dysmnesic phenomena. Epigastric rising sensation, 
fear, anxiety, and other emotional sensations suggestive of the involvement of 
amygdala are the common auras seen in TLE.  
2. Pseudo-absence – motor arrest, impairment of awareness and responsiveness. 
3. Automatisms – Oro alimentary, manual (fidgeting), ipsilateral upper limbs 
automatism, the contralateral posturing of upper extremities, ictal speech arrest 





 In the genetic form of neocortical epilepsy, there are two forms of genetic 
epilepsy. Autosomal dominant lateral temporal lobe epilepsy or autosomal dominant 
partial epilepsy with auditory symptoms, Sporadic form of lateral temporal lobe epilepsy 
with auditory symptoms. They will be presenting with auditory aura and other sensory 
auras frequently going for secondary generalization. The above forms of epilepsy have a 
good prognosis and they will very well respond to drug treatment. 
 
1.4.1.4. Frontal lobe epilepsy 
 It is the second most common type of focal epilepsy. The symptoms of frontal 
lobe epilepsy depend upon seizure onset zone at the frontal lobe. Seizures are often short, 
usually presenting with motor symptoms during sleep.Postictally, the patients with 
frontal lobe seizures, recover quickly with normal cognition. Patients may be presenting 
with paresis or paralysis of the limbs. Frontal lobe seizures are brief and bizarre. They 
may be misdiagnosed with psychogenic nonepileptic seizures. It is always confused with 
temporal lobe epilepsy because these patients with frontal lobe epilepsy often present 
with symptomatology of staring, unresponsiveness and late motor manifestation, versive 
head or eye movements and complex automatism. 
 
 The ictal clinical manifestation of frontal lobe seizures depends on the region of 
the frontal lobe where it arises 
15,19,20
. In areas of Prerolandic or primary motor cortex, 
the ictal manifestations may be focal motor seizures, with or without the Jacksonian 
march, speech arrest, dysphasia, and vocalisation. If epilepsy arises from Supplementary 
sensorimotor area located on the Brodmann area 6, medial or dorsal aspect of the frontal 
lobe, patient will have bilateral sensorimotor symptoms because of its bilateral 
11 
  
representation. Ictal manifestations may present with focal asymmetric tonic posturing, 
versive movements of head and eye, speech arrest, vocalisation and fencing seizures, 
bilateral asymmetric tonic seizure (tonic flexion of one arm and extension of the other 
with or without tonic leg involvement). These type of seizures are always partial even 
though there are bilateral motor manifestations with retained awareness. In patients with 
involvement of Dorsolateral prefrontal lobe, they may present with focal tonic-clonic 
activity, versive movements of head and eye, speech arrest or dysphasia. Patients with 
epilepsy involving orbitofrontal regions, ictal manifestations present with complex motor 
automatism, olfactory hallucination, illusion, autonomic features, bicycling movements 
involving the legs or windmilling movements in the arms. 
 
 Patients with epilepsy involving anterior frontopolar regions may present with the 
versive movement of head and eyes, forced thinking, initial loss of contact and absence 
like attack or motor arrest, bicycling in the legs or windmilling movements in the arms. 
Patients with epilepsy involving opercular region can have ictal presentations with 
Mastication, salivation, swallowing, laryngeal symptoms, speech arrest, aphasia, 
epigastric aura, fear, autonomic features, facial clonic activity or gustatory hallucination. 
If the cingulate area is involved, they may present with fear, vocalisation, emotional or 
mood changes, complex motor automatism and autonomic features. If negative motor 
cortex (posterior aspect of the inferior frontal gyrus or near the supplementary 
sensorimotor area)is involved, they may present with an inability to move a limb or a 
body part. Clinical characters of frontal lobe epilepsy are brief motor seizures, 
stereotyped movements occur multiple times at night, normal intelligence and normal 






1.4.1.5. Parietal lobe epilepsy and occipital lobe epilepsy 
 Occipital or parietal lobe seizures are difficult to diagnose with specific clinical 
symptoms because of the extensive and complex connection between the two lobes. 
Usually, visual symptoms are elementary visual auras and are more common in occipital 
lobe epilepsy. Ictal blindness, blinking and ocular movements are also experienced. 
Visual scenes or objects during ictus suggest spreading of discharge from the temporo 
occipital region. Seizure generating from temporal lobe below the calcarine sulcus are 
reported to spread to the temporal region with complex partial symptomatology. Foci 
above the calcarine sulcus are reported to spread to the parietal and frontal lobe. Parietal 
lobe seizures present with somatosensory auras contralateral to the seizures focus. 





 EEG investigations may show interictal spikes and focal slow waves not only at 
parietal or occipital region but also seen at temporo-frontal regions because of increased 
synaptic connections. False localizing EEG findings are reported to be observed at the 
midline with parietal and occipital foci. Malformation of the cortical development and 
tumors are the common pathology  seen in parieto-occipital lobe epilepsy. 
 
1.4.1.6. Insular lobe epilepsy and cingulate lobe epilepsy 
 Focal epilepsy arising from insular cortex is uncommon, but symptoms involving  
insular region are a contraction or choking sensation at the oropharynx and the larynx 
.Painful sensory aura in the throat may be due to seizure originating from cingulate or 
insular cortex. In these patients,invasive EEG may confirm the diagnosis. MRI of this 






1.4.2. Generalized seizure  
Generalized seizures are a group of seizures that present with various clinical 
manifestations and loss of consciousness 
14
. There are different types of generalized 
seizures as follows:  
 
1.4.2.1. Absence seizure 
 Absence seizures are characterized by sudden behavioral arrest, stare and 
unresponsiveness and brief rotation of the eyes upward for few seconds to half a minute 
with abrupt cessation of symptoms. The patient will be fully conscious and continue 
his/her activity what he/she was doing prior to the seizure onset. 
 
There are five subtypes of absence seizures reported in literature 
1. with impairment of consciousness only. 
2. with mild clonic components. 
3. with atonic components.  
4. with tonic components. 
5. with automatism. 
 
 Absence seizures may present with mild clonic components and clonic 
movements of the eyelids, corner of the mouth and the upper extremities at the frequency 
of 3 Hz which causes the head to drop, trunk to slump forward, the arms to drop or the 
grip to relax and falls are rare. Tonic muscle contraction of the neck extensor and the 
trunk muscles leads head to extend and trunk to arch causing retropulsion. Absence with 
automatism includes lips licking, chewing, lips smacking, swallowing, grimacing, 
smiling, yawning, fumbling with the hands, picking, scratching, rubbing or aimless 
walking. Absence seizures with autonomic phenomena are another subtype with signs of 
14 
  
tachycardia, pallor, flushing, piloerection, salivation or urinary incontinence. Complex 
absence seizures are a mixture of clonic, atonic, tonic, automatic and autonomic 
symptoms with absence features. Usually, the clinical events may be induced by 
hyperventilation and less commonly with photic stimulation in the laboratory. EEG may 





1.4.2.2. Generalized tonic-clonic seizure 
 Also known as grand mal seizures characterized by abrupt loss of consciousness 
followed by tonic contractions of the muscles and leads to ictal cry. The ictal cry is due 
to the forceful expiration of air against closed glottis. The mouth is tightly closed leads to 
tongue bite, pupils are dilated, eyes are deviated upwards. Upper limbs are abducted and 
flexed at the elbow. Lower limbs are  briefly flexed and then extended and later  
abducted with toes pointed. Clonic activity are initially rapid and then slows. Gasping 
respiration occurs if the respiratory muscles are involved in the clonic activity. 
Sometimes the patient may become cyanotic. Incontinence of urine may occur. The 
patient may become unconscious for a brief period. 
 
 A tonic-clonic seizure may be manifested as focal seizure, may arise from other 
generalized seizures or occur during secondary generalization of a partial onset seizure. 
Primary generalized epilepsy may be bilaterally symmetric or involve a forced head 
deviation to either side. In secondary generalized partial onset seizures, the contralateral 
arm extends and the ipsilateral arm flexes at the elbow and it occurs with the legs also. 
Tonic-clonic seizures may lead to injuries such as burns, head injuries, vertebral 






1.4.2.3. Myoclonic seizure 
 Myoclonic seizures are generalized seizures characterized by brief, irregular, 
shock-like jerks of the head, trunk or limbs. They can be symmetric or asymmetric and 
involve the whole body, regions of the body or focal areas. Myoclonic seizures can be 
sometimes idiopathic generalized epilepsies, symptomatic generalized epilepsies, 
progressive myoclonic epilepsies and infantile spasms. Myoclonus may be positive or 
negative. Negative myoclonus refers to the brief loss of postural tone when the body part 
is held against gravity. Consciousness is not impaired and no postictal confusion occurs 
after single myoclonic jerks. Myoclonic seizures can occur in clusters and evolve into 
clonic-tonic-clonic seizures with resultant loss of consciousness and postictal confusion. 
The ictal EEG pattern is characterized by brief generalized poly spike or polyspike and 




1.4.2.4. Tonic seizures 
 Tonic seizures involve tonic contraction of the face, neck, axial or appendicular 
musculature lasting from 10 sec to 1 min involving extension or flexion of the muscles 
and often lead to falls and head injuries, upward eye deviation. Usually seen in patients 
with symptomatic generalised epilepsy, Lennox-Gastaut syndrome, and myoclonic-
astatic seizures. The ictal EEG usually shows a brief generalised attenuation of cerebral 




1.4.2.5. Clonic seizures 
 Clonic seizures are generalised seizures characterised by repetitive rhythmic 
clonic jerks (1Hz to 2Hz) with impairment of consciousness and a short postictal phase. 
They can lead to a clonic-tonic–clonic seizure. Repetitive discharges are due to rhythmic 
excitatory discharges from the cortex. The ictal EEG shows polyspike and wave 
16 
  




1.4.2.6. Atonic seizures 
 Atonic seizures are characterised by sudden loss of muscle tone, head drop, limb 
drop or a drop of the whole body, loss of consciousness and injuries occur particularly to 
face. Tonic seizures last less than 5 seconds and are followed by minimal postictal 
confusion. The criteria distinguishing between negative myoclonus, atonic seizures, and 
some atypical absences need to be developed. Atonic seizures are usually seen in 
symptomatic generalised epilepsies, such as Lennox-Gastaut syndrome. The ictal EEG 
typically shows a generalised high voltage spike and wave or slow wave followed by a 




1.4.2.7. Unclassified epileptic seizures 
 Those seizures that will not come under classification because of incomplete data 
are classified as Unclassified epileptic seizures. For example, during infancy chewing, 
swimming movements, eye movements, jittering and apneic spells are not typed under 





1.5. Aetiology of refractory epilepsy 
 Various causes have been reported in the literature. Malformations of cortical 
development, head injury, cerebrovascular disorders, central nervous system (CNS) 
infection, pre and perinatal factors, CNS malformation, chronic alcoholism, 
encephalopathy, cerebral tumor, degenerative diseases, autoimmune diseases, 
calcification, gliosis, cerebral atrophy, and other causes are often associated with 
intractable epilepsy. Epilepsy is reported to be due to perinatal problems (48%) and 





Commission recommends using terminologies genetic, structural-metabolic, and 





1.6. Pathophysiology of intractable epilepsy 
 Most of the patients suffering from epilepsy of various types respond to 
antiepileptic drugs, and they are completely free from developing attacks. But still, 30 % 
of epileptic patients continue to develop recurring attacks of seizures in-spite of adequate 
and appropriate antiepileptic drug therapy. The definite mechanism underlying this state 
is not understood. Hence various hypotheses have been postulated. They are target 





1.6.1. Hypothesis for intractability  
1.6.1.1. Target hypothesis 
 Acquired alterations to the structure and functionality of target ion channels 
including neurotransmitter receptors. It explains how acquired structural and functional 
change at the target ion channels and neurotransmitter receptors lead to intractable 
seizure 
29
. Most of the antiepileptic drugs (AEDs) act on targets of voltage-gated cation 
channels (α subunits of voltage-gated Na+ channels and T-type voltage-gated Ca+ 
channels) and also the influence of the gamma-aminobutyric acid (GABA-mediated 
inhibition) are very important to increase the inhibitory potential. 
 
 T –type Ca2+ channels are expressed at the postsynaptic region, not present at the 
presynaptic regions are acted on by the particular AED and inhibit postsynaptic 
excitatory influence, thus preventing the depolarization of the epileptic neuron. Any 
modification in these receptors either due to genetic or acquired causes reduces the 
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efficacy of given AED at the target level due to the following factors:  
 
1. Down-regulation of the voltage-gated Na+ channels, β subunits, 
2. altered α subunits expression, 
3. induction of neonatal Na+ channels II and III α isoform mRNAs,  
4. Changes in GABA-A receptors decrease in α 1 subunits and increase of α 
4subunits,resulting in reducing GABA and benzodiazepines affinity for their 
receptors.  
 
 Thus modification of specific targets occurs and this results in seizure activity. 
 
 Mechanism of excitotoxic neuronal cell death and development of intractable 
epilepsy. 
 
 The GABA and Glutamate are the two important biochemical markers involved 
in epilepsy. It is very well known how GABA and glutamate are produced. Glutamate is 
a neuroexcitatory and GABA is a neuroinhibitor. The dynamic balance between these 
two neurotransmitters leads to the normal function of the brain. The imbalance between 
these two neurotransmitters results in seizures. The increase of excitatory 
neurotransmitter (glutamate) at the extracellular level of the receptors results in over-
excitation of neurons. Thus these excited neurons unable to recover from the tonic  
excitation and results in death of the neurons .The neuronal death leads  to permanent 
injury and it paves the way for seizure activity resulting in intractable epilepsy. 
 
 The C junction N –terminal kinases (JNKs) are members of mitogen activated 
protein kinases (MAPKs) family. It is activated by neurotoxins such as kainic acid, beta 
amyloid, and nitropropionic acid.Thus activation of JNKs results in increased neuronal 
excitation and cell death. Experimental evidence confirms drugs blocking the access of 
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the enzyme C JNKs to their substrate C JUNCTION may offer neuroprotection and 
prevent cell death. Thereby AED may be developed in future targeting the JNKs activity 
over the C junctions. 
 
Genes and intractable epilepsy 
Alterations of Sodium Channel 
 Genetic, epigenetic and exogenous factors lead to alterations at the site of action 
of the drugs. The genetic drug resistance is due to mutations in genes encoding the 
specific receptors. For example, voltage-gated Sodium channel (VGSC) subunits. They 
are SCN1A gene located at chromosome 2q24.3 linked to myoclonic epilepsy of infancy 
or Dravet Syndrome and Generalized Epilepsy with Febrile Seizure Plus (GEFS+).  In 
SCN1A gene exon 5 encodes for one of the four voltage-sensitive channel, the 1-S4 
domain. There are two versions. One is neonatal (N) and another one is an adult (A) 
which differ in three amino acid components. Polymorphism of SCN2A gene encodes 
for alpha 2 subunit of the neuronal sodium channel.  Mutations in the gene encoding for 
beta1 subunit has been linked to GEFS+.  
 
Alteration of Voltage-Dependent Calcium (Ca+) Channels 
 Repeated seizures promote transcriptional or post-transcriptional changes leads to 
structural changes in Voltage-Dependent Calcium (Ca+) Channels (VGSC). Voltage-
gated calcium channel VGCC are excitatory.  The T- type calcium channels are low 
threshold Ca
2+
 channel involved in thalamocortical discharges and also involved in  the 
pathophysiology of absence seizures.  The alpha 1G subunit of the T-type calcium 
channel is related to the generation of spike and wave discharges, whereas the alpha1 
subunit has no physiological property. The imbalance in the distribution of alpha1 and 




Alteration of GABA channels  
 GABA is an inhibitory neurotransmitter in the adult brain. There are two GABA 
receptors. GABA A and GABA B.  GABA-A is the binding sites for benzodiazepines 
and barbiturates.  GABA-A channels  have seven different subfamilies (α, β, γ, δ, π, θ 
and ρ). 
 
 Changes in the composition of the channel may lead to its role and sensitive to 
AEDs.  Molecular and functional studies reveal the transcriptional changes occur in the 
alpha subunit of the GABA-A receptor which decreases in the alpha1 subunit expression 
and increases in the alpha 4.  Pathogenic alteration or mutation in genes and structural 
abnormalities in chromosomes (insertions and deletions) result in varieties of epilepsies 
most of them are drug-resistant. 
 
GABA system abnormalities in intractable epilepsy: 
 GABA system is a ubiquitous system, and some different genes regularise the 
genesis of various receptors subunits, interacting proteins, transporters, synthesis and 
metabolism of enzymes. GABA is synthesised by decarboxylation of glutamate by 
glutamic acid decarboxylase (GAD). GAD exists in two forms; GAD65 and GAD67. 
Degradation of GABA requires GABA-transaminase (GABA-T) to convert GABA to 
succinic semialdehyde (SSA) by transamination with the co-substrates glutamate and 
alpha-ketoglutarate (alpha-KG).  SSA is subsequently oxidised by SSA dehydrogenase 
(SSADH) to succinate, a constituent of the tricarboxylic acid cycle (TCA). Inhibition of 




 Since glutamic acid decarboxylase is dependent on pyridoxal phosphate as the 
coenzyme, carbonyl trapping agents like derivatives of hydrazine are convulsant in 
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nature (Tapia and Pasantes, 1971).  At the nerve terminal, GABA can be released into the 
synaptic cleft by two different pathways.  1. Calcium-dependent vascular release or 
calcium-independent release via transporter reversal.  The release of GABA at the 
synaptic cleft mediates its action via two classes of receptors, ionotropic GABAa 
receptors and GABAc receptors and metabotropic GABAb receptors. Unlike GABAa 
and GABAb which form chloride channel and are involved in fast synaptic inhibition.  
The GABAb Receptors are guanine nucleotide binding (G) protein-coupled receptor that 
modulates calcium and potassium channels and elicits both presynaptic and slow 
postsynaptic inhibition.  After dissociation from the receptors complex, GABA is 
transported back into presynaptic nerve terminal or surrounding astrocytes via the GABA 
transporter system thereby terminating the GABA’s inhibitory action.  Neuronal GABA 
transport system is more efficient than astrocytic GABA transport system.  The 
deregulation of GABA is by the enzymes GABA transaminase and succinic 
semialdehyde dehydrogenase yielding succinate.  GABA transaminase is located in both 
neurons and astrocytes with the highest activity in the neuron.  GABAa receptors are 
pentameric complexes of subunits form an integral anion channel permeable to chloride 
and bicarbonate ions.   
 
 GABAa receptors are composed of two alpha subunits which in turn are 
presented in 6 isoforms  (α1 to α6) that contribute to the binding site of GABA 31,32 and β 
subunits with 3 isoforms, i.e., β1, β2S, β2L and β3 and one γ subunits (γ1,γ2S,γ2L and 
γ3 ). This different combination of isoforms and their assembly determines the properties 
of GABAa receptors, i.e., affinity for gamma-aminobutyric acid (GABA), allosteric 
modulation, interactions with intracellular proteins, the probability of channel opening, 
kinetics and conductance.  Hence changes in the composition of the receptors subunits 
appear to affect the function of GABAergic neurotransmission.  GABAergic system 
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modulating synaptic excitability and plasticity in the cerebral cortex generating rhythmic 
activity in cortico-thalamic circuits relying on primary afferent input to the spinal cord 
and brain stem and modulating the activity of dopaminergic and other monoaminergic 
neurons.  These Receptors have been implicated in neurologic and psychiatric disorders. 
For example - Absence seizure and autoimmune limbic encephalitis fast synaptic 
GABAergic transmission rely essentially on chloride- fluxes through GABAa receptors 
for which the maintenance of electrochemical chloride gradient is crucial to determine a 
GABA-mediated neuronal effect.  Changes in neuronal Chloride homoeostasis affect 
GABAa receptors mediated transmission and may contribute to epileptic activities. 
 
 The cation chloride transporters (CCCs) regulates cellular volume and play a 
crucial role in the cellular electrochemical Cl- gradient.  Functionally CCCs are grouped 
into three types:  
 
1. NKCC1, NKCC2 (cotransport Na+/ K+/2Cl-) towards the inside of the cell.  
2. KCC-14(K+/Cl-) towards outside of the cell. 
3. NCC ( Na+/Cl-) towards inside of the cell. 
 
 All CCCs are expressed in neurons or glial cells or both. 
 
 NKCC2 exclusively expressed in neurons and responsible for maintaining 
neuronal electrochemical chloride gradient. In an immature neuron, the level of NKCC1 
is higher than KCC2, and thus the intracellular chloride concentration is higher than the 
extracellular chloride.  GABAa receptors activation induces membrane depolarization 
and neuronal excitation throughout chloride efflux.  The opposite reaction occurs in the 
mature neuron. The level of KCC2 is higher than NKCC1. Thereby GABAa Receptors 




 In temporal lobe epilepsy, alteration in subunits architecture of GABA receptors 
noted in hippocampal tissues resected from TLE and non-TLE patients compared with 
controlled tissues at autopsy.  These findings are also found in cortical dysplasia with 
intractable seizures. Changes in relative expression of NKCC1 and KCC2 may be the 
contributing factor for epileptiform activity in the subicular region adjacent to sclerotic 
areas of the hippocampus.  
 
Genetic abnormalities in GABA Receptors in intractable epilepsy: 
 Changes in GABAa receptors subunit genes have been linked to different types 
of idiopathic and cryptogenic epilepsies that are drug resistant. The following genetic 
alteration of GABA receptors has been studied that is  
1. Coding sequence missense mutations 
2. Coding sequence nonsense mutations 
3. Coding sequence frameshift mutations 
4. Non-coding sequence mutations (intronic or 5 upstream) 
 
 GABA receptors mutations associated with changes in receptor function 
(impaired channel gating) imparting receptors biogenesis, (impaired subunit messenger 
RNA transcription, and stability subunit holding, stability or receptors trafficking.  The 
following genes have genetic alterations which are associated with human refractory 
epilepsy.  
1. GABA aminobutyric acid A receptor alpha1 gene 
2. GABA aminobutyric acid A receptor delta gene 
3. GABA aminobutyric acid A receptor gamma2 gene 
4. GABA aminobutyric acid receptor beta 3 gene 




 Modulation of the GABAergic function is very important in epilepsy treatment.  
It gives rise to changes in sensitivity of recognition of the binding site and alterations in 
the GABA binding and thereby agonist activity is established.  It is very important to 
understand the biomolecular physiology of the neuronal GABA system to develop newer 
drugs in future. 
 
1.6.1.2. Transporter hypothesis 
 Transport hypothesis states that intractability of seizure occurs due to an 
inadequate entry of AEDs across the blood brain barrier. It explains how the distribution, 
metabolism, and elimination of antiepileptic drugs depend on the pharmacokinetic 
process by which the drug reaches the appropriate target regions which are very crucial 
for the seizure control. This pharmacokinetics of antiepileptic drug is being affected by 
special proteins such as p glycoprotein, breast cancer resistance protein and multidrug 
resistance protein secreted at the cellular wall which is genetically determined. These are 
drug efflux transporters from the ATP binding cassette (ABC superfamily). The 
upregulation of this system leads to reduced bioavailability of antiepileptic drug at the 




Molecular mechanism in intractable epilepsy 
 Several hypotheses have been proposed to describe molecular mechanisms in 
intractable epilepsy. Transport and target hypothesis as described above explain the 
pharmacodynamics in intractable epilepsy. Target hypothesis can explain possible 
mechanisms related to channels that lead to morphological changes of the same. Drugs 
may not be able to act due to changes in the morphology of the ion channels. Molecular 
alteration at the drug receptor sites may lead to a reduction in drug effectiveness and 
drug action.  Transporter hypothesis suggests increased secretion of the efflux proteins 
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(p-glycoprotein) at the cellular wall which prevents the entry of AEDs from crossing the 
blood brain barrier and acting to stabilise the cell membrane. This may be due to 
increased expression of multiple drug resistance (MDR -1) genes. Overexpression of 
MDR protein either due to genetic causes or AEDs themselves induces the cells to 
secrete more drug efflux proteins. The above-said mechanisms are classical biological 
reactions involved in the brain during drug treatment in epilepsy. The pharmacodynamic 
response (PD) refers to the effects caused by drugs on individuals. The pharmacokinetic 
response (PK) refers to the concentration of active ingredients of the drugs administered 
(AED) in different body tissues or fluids, and it is the result of action exerted by the body 
on the administered molecules. The PK and PD play a major role in serum drug level and 
the clinical response of the individual to that particular drug. In intractable epilepsy 
overexpression of multidrug transporters not only caused by genetics and also by the 
administered antiepileptic drugs and sometimes spontaneously due to seizure activity 
itself.  The resistance to multiple drugs could not be explained using single mechanism 
or hypothesis. A multidrug drug-resistant epilepsy model as adapted in cancer 





1.6.1.3. Gene variant  hypothesis 
 An inherent resistance maintained by genetic variants of proteins involved in the 
pharmacokinetics and pharmacodynamics of AEDs action. The unpredictability in the 
efficiency of controlling seizures, adverse drug reactions and optimal doses required in 
individual patients when treating epilepsy with AED may be a consequence of genetic 
variation.  The AED pharmacokinetics and pharmacodynamics are clearly due to genetic 
polymorphism.  Single nucleotide polymorphisms (SNPs) and variations at a single site 
in the DNA are the most frequent forms of sequence variations in the human genome,and 
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it may affect the efficacy, tolerability and duration of action of AEDs.   In both target and 
transporter hypotheses,  the genetic variants pave the way for abnormal drug transport 
and alteration in the drug targets.  Inherent severity disorder is the determinant of the 
treatment outcome. For example, a number of attacks in the early phase of the 
illness/disease leads to intractable seizure which may be due to factors operating at 
extracellular and intracellular level (intrinsic and extrinsic mechanism).  The genetic 
basis 
34
 has a role in this mechanism. 
 
1.6.1.4. Network Hypothesis 
 Neural network hypothesis state that “seizure-induced alterations of brain 
plasticity including axonal sprouting, synaptic reorganization, neurogenesis, and gliosis 
could lead to the formation of abnormal neural network, which has not only avoided the 
inhibitory effect of endogenous antiepileptic system but also preventing the traditional 
antiepileptic drugs from entering their targets, eventually leading to intractable 
epilepsy”35.  The above changes lead to adaptive remodelling of the neural structures 
after the attack of seizure may lead to permanent epileptic neural circuit causing 
intractable epilepsy. 
 
 This hypothesis reveals that refractory epilepsy is a complex and multifactorial 
disease. Single hypothesis or multiple hypotheses may be operating in a given intractable 
epilepsy patient.  Acquired or genetic background or both may be important in studying 
patient with intractable epilepsy. Understanding the above hypothesis is very important 
to do research in developing newer drugs and nonpharmacological ways to treat drug-






Role of neural network in intractable epilepsy 
 Brain function is a result of the activity of neural network connecting cortical and 
subcortical systems. Epilepsy is a dynamic disease of this neural network. When the 
normally functioning brain jumps to another state causes abnormal oscillation resulting 
in epilepsy which lasts for few seconds to minutes and returns to normal state. From the 
review of literature two systems appear to be involved in displaying epileptic behaviour: 
1. Thalamocortical system  is a pacemaker in generalised epilepsy 
2. Mesial temporal system  is involved in temporal lobe epilepsy 
 
 Increased up-regulation and decreased down-regulation of the ionic channel and 
synaptic strength is the causes for the genesis of seizure. The homeostatic mechanisms 
possessed by neuronal network operate over different temporal and spatial scales. This is 
observed not only in neocortical cells but also in hippocampal pyramidal neurons. The 
synaptic strength is often balanced by long term potentiation and long term depression. 
The homeostatic mechanism of regulation of neuronal excitability is maintained by 
regulation of synaptic strength and ionic channels that translate changes in membrane 
potential into a pattern of action potential firing. Three main processes have been 
implicated in signalling pathways for synaptic scaling: a) brain-derived nerve growth 
factor (BDNF), tumor necrosis factor α (TNF α), and intracellular Ca2+. Administration 
of BDNF can prevent the upscaling synaptic strength in vitro suggest a role of BDNF as 
a possible signalling molecule. The cytokine TNF α once released from the glial cells can 
also upscale the synaptic strength in neurons which was decreased by tetrodotoxin. Ca
2+ 
that modulates the synaptic strength is disturbed in epilepsy leading to shifting      in 




 Post deafferentation epileptogenesis plays a major role in post-traumatic 
epileptogenesis. The upregulation of excitatory synapses between pyramidal cells 
mediated by AMPA receptors, either with or without a concurrent downregulation of 
inhibitory synapses and upregulation of excitatory synapses. Deregulations of excitatory 
input due to ion accumulation, osmotic changes and cell swelling are sufficient to initiate 
the process of seizure. 
 
 All the mechanisms finally lead to form a seizure network, that is initiated by 
high-frequency firing in the pyramidal cell and axon plexus resulting in very fast 
oscillation (VFO).VFO is initiating factor for seizure activity.This depends upon the 
special extracellular condition such as alkaline state at the extracellular space, lowering 
of calcium, elevation of extracellular potassium to open the gap junction. It iswell-
demonstrated in-vivo and in-vitro experimental studies. The activity of VFO in epileptic 
patients being recorded by using MRI 
1, 17
 in addition to EEG or electrocortical graphic 
recordings. The above information helps us to approach and treat intractable epilepsy 





 Proteomics is a science that deals with proteome. A number of proteins expressed 
in a cell or in a tissue or in an organism which is determined by genes. It may be altered 
by cell or tissue or organism due to internal status, external stimulations or 
developmental changes 
37
. The proteins are modified by phosphorylation, ubiquitination, 
palmitoylation, oxidation and post-translational modification. Proteomics is used to 
search for biomarkers associated with the disease. It is also used in agronomy researchers 
(sugarcane and wheat). In Neurology proteomics technology is applied to understand the 
cell mechanism is called as neuroproteomics or neuromics. The neuroproteomics helps 
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us to study proteome of brain fragments or single cell to determine the dynamics of 
subproteome under different conditions. Proteomics is a multi-disciplinary method which 
is based on principle, biochemical, biophysical and bioinformatics. Proteomics analysis 
has four basic stages: extraction, purification, separation and identification of proteins. 




 In epilepsy, the study of proteomics is used to identify biomarkers associated 
with epileptogenesis. There are several biomarkers such as Isoform 1 ofa serum albumin 
ALB, Heat shock-related 70 kDa protein -2(HSPA2), Dihydrolipoyllysine – residue 
acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial – 
dihydrolipoyl acetyltransferase etc, identified as potential proteins expressed in the 
hippocampus of patients with intractable epilepsy. 
 
Autoantibodies 
 The central nervous system is protected from the infection  by the blood-brain 
barrier and it is not equipped with the immune systems that are represented in most other 
organs. When the blood-brain barrier breaks down, immune cells from the vessels 
supplying the brain seep into the brain causing an inflammatory reaction. Lack of 
histocompatibility also is a factor which is unique to the brain cells. Microglial cells are 
considered as the macrophages of central nervous system. These cells participate in the 
expression of T like receptors cells (TLRs). TLRs will produce cytokines (interleukin 
1,6,12, interferon type 1, and TNF-alpha).  Microglial cells invade the brain forming a 
protective network of the potential effector cells throughout the CNS. Astrocytes are 
other CNS cells which are also involved in the immunological functions by suppressing 
T helper 1 and 2 cells activation, proliferation and effector functions of the activated T 
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cells. All these mechanisms lead to apoptosis of CNS cells. Astrocytes have a crucial 
role in  formation and maintenance of  the blood-brain barrier. 
 
 Inflammation of the CNS occurs in autoimmune reaction, epilepsy, trauma, 
infection and ischemia. The above-mentioned cells particularly the inflammatory cells 
are released in the CNS after the breakage of the blood-brain barrier. The TLRs are 
transmembrane proteins expressed by immunocompetent cells (APC cells- antigen 
presenting cells) are activated. The cells will release cytokines and chemokines, proteins 
of the complement system cyclooxygenase-2 and nitric-oxide synthase. An immune 
response in the CNS may be triggered by endogenous ligands that stimulate TLR. 
 
 The immune system is involved in the pathogenesis of certain type of epilepsy. 
Example the limbic encephalitis is a form of autoimmune encephalitis where the patient 
will be presenting with intractable epilepsy. This is evidenced by detection of elevated 
levels of the proinflammatory mediators in CSF and serum in patients with autoimmune 
encephalitis and some types of febrile seizures. The inflammatory activity is affected in 
different ways by an intractable seizure. When the seizure is intractable, increase in 
levels of interleukin 1,6,12, interferon type 1, and TNF-alpha is observed. In the case of 
Rasmussen encephalitis in addition to cell death due to CD8 and T cell mediated attack, 
the autoantibodies also found at the site of inflamed regions signifying various 
immunological mechanisms in addition to cell mediated destruction. 
 
1.7. Structural abnormalities in intractable epilepsy 
1.7.1. Computerised tomography and Magnetic resonance imaging  
 Computerised tomography (CT) and Magnetic Resonance Imaging (MRI) are 
routinely used in epilepsy to identify various congenital and structural abnormalities in 
the brain. CT can accurately detect haemorrhage, infarctions, gross malformations, 
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ventricular system pathologies, and lesions with underlying calcification 
41
.  The 
sensitivity of CT in patients with epilepsy is not higher than 30%.  CT has overall a low 
sensitivity and poor resolution in the temporal fossa. Thus CT is not useful in detecting 
mesial temporal sclerosis, the most common pathology in intractable temporal lobe 
epilepsy 
42
. The sensitivity of MRI is high in detecting abnormalities in patients with 





1.7.1.1. Malformation of cortical development 
 Malformations of cortical development (MCD) are microscopic and macroscopic 
developmental abnormalities of the cerebral cortex that arise due to an interruption in 
cortical development during fetal development by genetic or environmental factors 
46
. 
According to Barkovich classification, MCDs are classified into three groups 1) 
malformations due to abnormal neural proliferation, 2) malformations due to abnormal 
neuronal immigration, and 3) malformations due to the abnormal cortical organisation 
47
. 
Due to recent advances in Magnetic Resonance Imaging (MRI) used in patients with 
epilepsy, the fourth group of malformations of cortical development is added to 
Barkovich classical classification as “not otherwise classified”.  
 
 There are very few studies in the literature regarding the prevalence of MCD in 
drug-resistant epilepsy. The prevalence of MCD reported being high in children with 
drug-resistant childhood epilepsy ranging from 25% to 40% 
43,45,48
. In adults, the 
prevalence of intractability among patients with MCD is reported to be 84.8% 
49
 in a 
large series of patients with epilepsy (N=3000). With recent advancement in radiologic 
imaging techniques, the identification of MCD has increased significantly 
46,50–53
. Studies 






Figure 1: Pictorial representation of normal hippocampus and  




cortical dysplasia, Polymicrogyria, Lissencephaly, heterotopias, dysembryonic 
neuroepithelial tumor, Hemimegalencephaly and others 
50,52,54
. Clinical features of 
MCDs are often heterogeneous. MCD exhibit seizures majorly complex partial seizure to 
any other form of seizures 
49,52
, family history 
49,52
, usually drug resistant and  intractable 
49,50
, change in semiology 
51
, associated with febrile seizures 
52
, present with delayed 
motor or mental milestones 
52,54
, cognitive deficits and learning disability 
49,55
. About a 
third of patients with MCD had hippocampal abnormalities like the hypoplastic 
hippocampus, hippocampal sclerosis, malrotation of the hippocampus, and enlarged 
hippocampus 
55
. Febrile seizures with Focal Cortical Dysplasia (FCD) are reported to 
have dual pathology (FCD with hippocampal sclerosis) 
51
. Many patients with FCD 
report initial seizure semiology as a tonic or generalised tonic-clonic seizure. 
 
1.7.1.2. Incomplete hippocampal inversion 
 Incomplete hippocampal Inversion (IHI) is a failure of hippocampal inversion 
that occurs during normal fetal development which can be diagnosed with MRI and often 
reported to be pathological in patients with seizures 
56
. Normal hippocampus and its 
orientation of head, body and tail arepictorially represented in figure 1. Recent studies on 
patients with temporal lobe epilepsy (TLE) and MCD have reported that IHI can be 
found in a similar proportion of MCD and TLE 
57
. An excellent study by Bajic et al., 
have shown that IHI is observed in 30% of patients with epilepsy mostly on the left side 
followed by bilateral and right sided IHI 
58
. The presence of IHI has been reported to be a 
marker of a more extensive disorder of brain development 
57,58
. With the evidence of 
having IHI as a malformation of brain development, it would be a possible abnormality 




Figure 2: Pictorial representation of histopathological classification of MTS as described 




1.7.1.3. Mesial temporal sclerosis  
 The most common pathology seen in patients with intractable temporal lobe 
epilepsy is Mesial Temporal Sclerosis (MTS). MTS is pathologically characterised by 
the presence of atrophic hippocampus, increased signal on T2-weighted images or 
FLAIR (fluid attenuated inversion recovery) and decreased signal on inversion recovery 
sequences 
59–61
. Brain abnormalities especially MTS, either alone or in association with 
another lesion are major predictors of intractable epilepsy 
62
. MTS is classified 
histopathologically into three types namely, type 1a (classic hippocampal sclerosis 
involving severe cell loss in CA1 and moderate loss in other subfields except CA2), type 
1b (severe hippocampal sclerosis involving severe cell loss in all hippocampal subfields), 
type 2 (atypical hippocampal sclerosis involving severe neuronal loss restricted to CA1) 
and type 3 (atypical hippocampal sclerosis involving severe neuronal loss restricted to 
hilar region)
63
. Classification of MTS is pictorially represented in figure 2. Early brain 
insult (trauma, febrile seizures) is called as initial precipitating injury could lead to 
hippocampal damage resulting in type 1A, 1B pathology. In type 2 and type 3 the initial 
precipitating injury is reported to as result of late insult to the hippocampus 
63
. After the 
initial precipitating injury, most of the damaged cells in the hippocampus (inhibitory 
function) remain silent, but the dentate gyrus granule cell layer and its axons (mossy 
fibers) sprout into a molecular layer which is excitatory in function. After sprouting there 
is an excitation and inhibition mismatch leading to increased excitation resulting in 
recurrence of seizure with a change in terminology 
64
. The observation supports the 
concept that extensive bilateral hippocampal circuit rewiring leads to intractability in 




 T1 and T2 weighted images less than 3mm cuts will help us to evaluate 
hippocampus. The Smaller size of the hippocampus in intractable epilepsy is suggestive 
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of hippocampal sclerosis on the affected side. The increased T2 signal in the 
hippocampus suggestive of gliosis. Gradient echoes help to identify vascular lesions. 
Fluoro Deoxy glucose positron emission tomography (FDG –PET) a useful test in the 
presurgical evaluation of patients suffering from temporal lobe epilepsy. 
Hypometabolism in the temporal lobe ipsilateral to the seizures focus is a positive 
predictor of good outcome after epilepsy surgery. Hence it is useful only in people who 
are subjected to epilepsy surgery. In the genetic form of temporal epilepsy, images 
studies will be normal.In lateral or neocortical epilepsy lesions like malformation of the 
cortical development, vascular malformation, encephalomalacia secondary to trauma, 
inflammation, ischemia, haemorrhage and tumor are seen. 
 
1.7.1.4. Vascular lesions  
Most frequently encountered vascular causes of intractable epilepsy isarteriovenous 
malformations (AVMs) and cavernomas 
66
. In a large sample, 30% of AVMs are 
reported to be associated with a seizure. Most of the AVMs were reported to be located 
in temporal and rolandic region presenting with partial epilepsy, whereas frontal or 
Sylvian region AVMs were presenting with generalised seizures. 24.7% of patients with 
partial epilepsy were reported to be intractable
67
. The severity of the seizure depends on 
the size of AV malformation, haemorrhage and frontotemporal location
68
. Delay in the 




 Intractable epilepsy associated with tumors often present with focal epilepsies. 
Glioneuronal tumors most commonly arise from the temporal lobe. Studies on a large 
sample (N= 207) of patients underwent surgical resection of tumor associated with 
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intractable epilepsy showed 154 patients with classic epilepsy-associated tumors 
(dysembryoplastic neuroepithelial tumor, ganglioglioma, and pilocytic astrocytomas) and 
53 others tumors (astrocytomas and oligodendrogliomas) 
69
. Also, cortical dysplasia and 
other neuronal migration disorders often coexist with these tumors. These are all drug 




1.7.1.6. Post-traumatic epilepsy 
 Several studies have reported the incidence of post-traumatic epilepsy from 7-
31.9%  following brain injury 
71,72
. Closed traumatic brain injuries often cause 
haemorrhage, necrosis, edema and white matter lesions
 73
. Injury to neurons causes 
cellular loss with replacement of gliosis, changes in neuronal plasma membrane, sodium 




1.7.1.7.  Infections and epilepsy 
 Brain infections are reported to be the significant contributors of epilepsy by 
crossing blood brain barrier and causing neuronal loss. Recent studies suggest that 
subjects with chronic infections are susceptible to epileptogenesis and intractability of 
seizures. Due to epilepsy, evidence for inflammation of nerve cells is demonstrated by 
post-surgical studies
76
, hippocampal sclerosis (TLE)
77





  and antiepileptic effect of anti-inflammatory drugs in West, Landau-
Kleffner syndromes, Lennox–Gastaut syndromes 80. 
 
1.7.1.8. Post-stroke epilepsy 
 Stroke is the one of the common neurological disorder that can often be 
associated with epilepsy which adds on to the disability and increase complexity for 
treatment. Several studies have reported that seizures may occur approximately up to 
10% of patients following stroke 
81,82
. Individuals with stroke may present with early 
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seizure or late seizures following stroke (ILAE, 1993). Seizures are reported to be often 
associated with hemorrhagic strokes than ischemic stroke. Complex partial seizures are 
often reported to be present with early seizures whereas generalised tonic-clonic seizures 
are reported to be associated with late seizures after 2 weeks 
82,83
.  Acute Metabolic 
derangements associated with stroke cause early seizures that can be reversed. In 
contrast, late seizures cause structural changes like gliosis or meningo cerebral scar 
tissue 
84
. Changes in the cell membrane, neuronal loss and collateral sprouting are 
reported to cause excitation in epilepsy 
85
. Cortical infarction is most often reported to be 
resulting in seizure rather than subcortical involvement
 86
. Large cortical infarction 
87
 
especially the involvement of temporal lobe is often reported to a high-risk factor for 
developing post-stroke seizures. 
 
1.7.1.9. Calcification  
 Calcification occurs in the brain due to various factors like infections 
(toxoplasmosis, rubella, cytomegalovirus, cysticercosis, AIDS), calcium metabolism 
disorders, genetic (Cockayne syndrome, tuberous sclerosis, Fahr’s disease, down 
syndrome, and neurocutaneous syndrome like storage weber’s syndrome) or autoimmune 
disorders ( autoimmune encephalitis) and persistent inflammation. Focal cortical – 
subcortical calcifications are reported to be associated with focal or generalised epilepsy 
especially in India. 77.5% of patients with calcifications are reported to have focal 
epilepsy (partial seizures)
88
. Basal ganglia calcifications are often reported to be 
associated with hypoparathyroidism and pseudohypoparathyroidism. Intracranial 
calcifications are also considered as incidental in 0.3 to 1.5% of the patients 
89
.  
Calcification due to infections may be associated with perilesional edema. These patients 
have the tendency to develop seizures intermittently. The pathophysiology of the 





. Also, focal cerebral calcifications in CT scan are reported to be 
associated with gliosis around the calcified lesion on T1 weighted MRI images. 33.3% of 
patients with perilesional gliosis is reported to  have increased seizure frequency, and 




1.7.1.10. Metabolic disorder 
 Intractable epilepsy due to metabolic disorder is not rare in adults. The metabolic 
disorders may be due to small and large molecule disorders. Small molecule disorders 
include defective molecule or mechanisms related to amino acids,organic acids, fatty 
acids, neurotransmitters, urea cycle, vitamins,  cofactors, and mitochondria. Large 
molecule disorders include defective molecules and mechanisms related to lysosomal 
storage disorders, peroxisomal disorders, glycosylation disorders, and leukodystrophies. 
Epileptic encephalopathies are inborn metabolic defects that present with intractable 
epilepsy. They may present with intractable neonatal seizures, early myoclonic 
encephalopathy, early infantile epileptic encephalopathy, infantile spasms, and 
generalised epilepsies which in particular include myoclonic seizures 
92
. These disorders 
are reported to be rare in the adult population.  
 
1.7.2. Diffusion Tensor weighted imaging 
 Diffusion Tensor Weighted Imaging (DTI) is a recently developed MRI 
technique which has gained importance over time to assess abnormalities with focal 
epilepsy (Partial seizures) 
93–95
. DTI measures the molecular motion of water in tissue in 
various directions in every voxel, providing information regarding the microstructure of 
the white matter and grey matter, cellular packing, cellular loss or regional edema in 
focal status epilepticus 
96
.  In DTI, Apparent Diffusion Coefficient (ADC) and Fractional 





Diffusion tensor weighted images have been studied well on a small group of individuals 
with temporal lobe epilepsy (TLE) and extratemporal lobe epilepsy (ETLE).  
 
 Interictal DTI imaging studies are reported to be more sensitive in identifying 
hippocampal involvement rather than conventional MRI in TLE
 99
. Interictal imaging 
studies in patients with medial temporal lobe epilepsy associated with hippocampal 
sclerosis showed diffusion abnormalities involving pathologic hippocampus and larger 
network involvement 
100
. Diffusion tensor imaging in patients with epilepsy and MCD 





 Patients with partial seizures and normal MRI findings showed various areas with 
abnormal anisotropy or diffusion, which were normal in conventional MRI 
102
. Interictal 
studies in patient’s normal structural MRI and TLE shows bilateral and extratemporal 
lobe involvement 
95
. In TLE, lateralization of the epileptogenic region using DTI studies 
highly correlates with the presence of unilateral hippocampal sclerosis on conventional 
MRI 
103
.  And patients with non-lateralizing conventional MRI findings, the interictal 
DTI studies will not provide lateralizing information 
99
.From the review of the literature, 
there is ample evidence of DTI image abnormalities unilaterally or bilaterally,when MRI 
studies of the brain are normal or abnormal.  
 
1.7.3. Volumetric studies of hippocampus 
 Incomplete hippocampal Inversion (IHI) is a failure of hippocampal inversion 
that occurs during normal fetal development which can be diagnosed with MRI and often 
reported to be pathological in patients with seizures
 56
. Recent studies on patients with 
temporal lobe epilepsy (TLE) and MCD have reported that IHI can be found in a similar 
proportion of MCD and TLE 
57
. An excellent study by Bajic et al., have shown that IHI 
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is observed in 30% of patients with epilepsy mostly on the left side followed by bilateral 
and right sided IHI 
58
. The presence of IHI has been reported to be a marker of a more 
extensive disorder of brain development 
57,58
. With the evidence of having IHI as a 
malformation of brain development, it would be a possible abnormality causing 
intractable epilepsy. 
 
1.8. Neuropsychological manifestations in epilepsy 
 The psychiatric manifestations of psychosis, depression, anxiety and other 
behavioural disturbances can coexist with intractable epilepsy but sometimes they may 
manifest as a part of seizure, or they may be due to drugs 
104–107
. The psychiatric 
manifestations may worsen the existing epileptic condition. Gross impairment of 
cognition may be due to continuous seizure and drugs 
106–109
. Mood disorders, 
personality change, Attention deficit hyperactive disorders, language disorders are also 




 Anxiety and depression often coexist in individuals suffering from epilepsy 
104,111–115
. The prevalence of anxiety range from 11 to 25% and depression range from 9 
to 40% in persons with epilepsy across various studies when compared to individuals 
without epilepsy. The prevalence of anxiety and depression is often reported to be higher 
in individuals with drug resistant epilepsy and temporal lobe epilepsy 
105,110,116–119
. 
Depression and anxiety have also been reported to be often associated with suicide, 
suicidal ideation, suicidal attempts 
120–122
. Altogether anxiety and depression in patients 




 Most significant cognitive deficit in Temporal lobe epilepsy (TLE) patients, 
especially in patients with mesial temporal sclerosis, is memory impairment 
126,127
. 
Wechsler memory scale -III and Wechsler adult intelligence scale –Revised can 
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differentiate patients with refractory temporal lobe epilepsy from normal subjects, but 
they cannot differentiate between the right and the left TLE 
127
. Also, other factors 
including long-term antiepileptic drugs, the age of onset, duration of epilepsy, type of 





 Interictal Electroencephalography (EEG) in patients with intractable seizure 
shows generalised abnormality in 75% of the cases rest of the EEG showed focal 
epileptiform activities which correlate with their clinical conditions  
130
. In Focal cortical 
dysplasia, interictal routine video EEG was reported to show regional epileptic activity in 
89% of patients 
131
. When compared to routine EEG, intensive EEG monitoring was 





 Interictal electroencephalography (EEG) findings in MTLS – spike and sharp 
waves are seen over the anterior temporal region. Sleep deprivation sometimes activates 
focal epileptiform discharges. Therefore EEG with sleep recordings is recommended 
during diagnostic workup. The presence of mid and posterior temporal lobe spikes in 
EEG may suggest the widespread involvement of epileptic network. Even in the presence 
of normal medial temporal lobe, ictal EEG may reveal rhythmic, alpha or beta activity 
and evolve to rhythmic delta or theta activity. The seizure discharge may be limited to a 
medial temporal lobe, or it may spread to ipsilateral hemisphere and contralateral 
temporal lobe. Unilateral temporal lobe slowing in EEG is suggestive of ipsilateral 
seizure onset. Interictal EEG pattern almost same in neocortical epilepsy as seen in 
medial temporal epilepsy. But abnormal waves like spikes or sharp waves are seen over 
T4, T3, and T6, T5 and rapidly propagates to other lobes and quickly spread to opposite 
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side. Polymorphic delta pattern is also seen over above-said areas. 
 
 Dorsolateral and frontopolar epilepsies will be associated with focal epileptiform 
activity because the electrodes placement will be very easy. Foci arising from 
interhemispheric, orbitofrontal cortex and frontal opercular cortex cannot be recordable 
because of the difficulty in placing electrodes. The frontal lobe is very near to temporal 
lobe, so epileptic form of activity can also recorded in the anterior temporal electrodes. 
Bilateral secondary hypersynchrony has also described in patients with frontal lobe 
epilepsy. The epileptiform discharges appear as generalised spikes, polyspikes or spike 
and wave. It is always differentiated from frontal lobe epilepsy by locating unilateral 
epileptiform discharges before the generalised discharges. 
 
1.10. Optogenetics in epilepsy 
 Optogenetics is a technique in which light-sensitive protein called opsin is 
introduced into the cell thereby cells will shine. Opsin can stimulate light-sensitive 
channel, pumps, G- protein-coupled receptors and transcriptional receptors. The light-
sensitive channel and pumps can inhibit or excite the neurons. There are different kinds 
of  opsins playing at the cellular membrane. The important opsins are channelrhodopsin-
2(chR2) which are excitatory and Halorhodopsin (NpHR) which is inhibitory rhodopsin. 
Channelrhodopsin-2 and its variants are activated by blue light causing passive 
movements of Na +,k+,Ca2+ and H+ ions following the electrochemical gradient and 
thus depolarising the cell membrane and generation of action potential. Halorhodopsin 
on exposure to orange light causes active pumping of chloride ions into the cell results in 
hyperpolarization of cell membrane and inhibition of action potential generation takes 
place. 
 
 Light can be divided into lasers and light emitting diodes (LED) by different 
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wavelength and power. LED lights have increased wavelength and more power, easy to 
generate. This light is thrown into the cell via the optical fibres called optrodes.Thus the 
orange light, blue light and red light can be generated. Orange light has affinity over 
Halorhodopsin and glows, and blue light prefers channelrhodopsin. Opsins can be 
introduced into the cell via the vectors containing the particular inhibitory or excitatory 
opsins. Using LED sources throwing blue and orange light helps to identify the type of 
dominant opsins that is present over the cell membrane. Focal cortical seizures, temporal 
lobe seizures, and thalamo cortical epilepsy are diagnosed by finding out the cellular 
cause for increased excitability (either reduced Halorhodopsin or increased 
channelrhodopsin) and suitably treated with vector-mediated implantation of the 
appropriate opsins over the cell membrane.  
 
1.11. Surgical outcomes in epilepsy  
 Studies carried out on patients with MCDs especially focal cortical dysplasia was 
reported to have a good surgical outcome if evaluated and managed with electrical and 
imaging modalities 
133
. Also, favourable surgical outcomes were reported in children 
with temporal lobe epilepsy with MTS in developing countries when evaluated with a 
non-invasive protocol 
134
. Diffusion tensor weighted imaging studies are also reported to 


















2.1. Need for the study 
 From the review of the literature, studies using drug-resistant epilepsy criteria 
(ILAE, 2010) to identify its prevalence and clinical characteristics are sparse, especially 
in Indian context. There are few studies in India regarding the prevalence of intractable 
epilepsy 
27,130
 and its risk factors 
11
. They report various risk factors that contribute for 
intractability in the epileptic population. Identification of various risk factors responsible 
for intractability is reported to be associated with significant therapeutic implications. 
Several studies in western countries and  India identify various structural abnormalities 
like mesial temporal sclerosis, malformations of cortical development, vascular lesions, 
stroke, traumatic brain injury, calcification and infections as a cause for intractability 
which accounts for 60-70% of the population.  30-40% of them do not show any lesions 
may manifest with intractable epilepsy. With the advancement of neuroimaging 
technology especially DTI and volumetric studies, it would be possible to identify 
microstructural abnormalities and asymmetries that would contribute to intractable 
epilepsy. Identifying structural abnormalities or multiple lesions using various 
investigations would help in tracing the neural network responsible for epilepsy.  
 
 In developing countries like India, where accessibility to neuroimaging facilities 
are not easily available, the prevalence of intractable epilepsy and various structural 
lesions associated with them are largely unknown. There are few preliminary studies 
carried out in India to document the frequency and clinical characteristics of MCD 
among children 
52,136
 and adults 
52
. These are retrospective studies with data retrieved 
from case records of epileptic patients 
52
, and little is known about the prevalence of 
Mesial temporal sclerosis and incomplete hippocampal inversion in the Indian scenario. 
Studies in India using Diffusion tensor weighted images 
137
 are reported to be useful in 
identifying white matter structural abnormality among extratemporal epileptic patients. 
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DTWI is also reported to be helpful in predicting the postoperative neurological 
outcome, surgical decision making and preoperative counselling for the patients. 
 
 Moreover, it has been reported that structural abnormalities would give rise to 
focal seizures which may be the temporal or extratemporal type. Correlating the type of 
epilepsy, the age of onset, duration of seizure, status epilepsy, clustering and 
electroencephalography finding with structural lesions of the brain would guide us in 
predicting the possible clinical manifestations of those lesions. Also, intractable epilepsy 
associated with various structural lesions may present with various profiles of 
neuropsychological manifestations. Identifying the neuropsychological profile for each 
structural lesion would help us to approach clinically for further investigations and 
treatment planning. Intractable epilepsy being one of the important disorders causing 
disability, correlating structural abnormalities with demographic data and quality of life 
would reveal the psychosocial aspects of the patients.  
 
 To obtain seizure freedom from the recurring and debilitating seizures, 
understanding the mechanism involved in epilepsy, identifying neural networks and its 
clinical manifestations are essential. Surgical, medical management and rehabilitation 
measures are important to control seizures and improve the quality of life.  This can have 
a great impact not only on psychosocial aspects of patients and their family but also 
reflect on the country’s economy. So the present study was carried out to identify various 
structural lesions using different imaging techniques including CT scan, MRI, DTI and 
volumetric studies and to correlate with the demographic data, medical history, seizure 





1. There is no association betweenthe type of seizures (generalized and partial seizures)  
with demographic data (age, gender, employment, occupational status, educational 
level), clinical characteristics (developmental history, natal history, postnatal history, 
family history, age of onset , duration of seizure, seizure frequency,  clustering, 
precipitating factors, status epilepsy, neurological examination, comorbid conditions 
and drugs), psychological assessment findings (Intelligent Quotient (IQ), Mental 
quotient (MQ), Bender-Gestalt Test (BGT), depression and anxiety scores), structural 
imaging findings (Computerized tomography (CT) scan, Magnetic Resonance 
Imaging (MRI), Diffusion Tensor Weighted Imaging (DTI)), electroencephalography 
findings and Quality of life in adults with intractable epilepsy. 
 
2. There is no association between the type of structural lesions in MRI with the 
demographics, clinical characteristics, psychological assessment and EEG findings. 
 
3. There is no correlation of the side of abnormality across various neuroimaging 
investigation (CT, MRI, and DTI) and EEG with the type of seizure. 
 
4. There are no differences between the sensitivity of imaging techniques (CT, MRI, 



















 To investigate the prevalence, demographics, clinical characteristics, 




1. To estimate the prevalence of intractable epilepsy in adults who attend epilepsy 
clinic, Institute of Neurology, Rajiv Gandhi Government General Hospital.  
2. To assess the educational, occupational status, clinical characteristics, psychological 
status, EEG and structural abnormalities in patients with intractable epilepsy. 
3. To compare type of seizure (generalized and partial seizures)  in adult intractable 
epilepsy patients with demographic (age, gender, employment, occupational status, 
educational level), clinical characteristics (developmental history, natal history, 
postnatal history, family history, age of onset , duration of seizure, seizure frequency,  
clustering, precipitating factors, status epilepsy, neuro examination, comorbid 
conditions and Drug), psychological assessment findings (Intelligent Quotient (IQ), 
Mental quotient (MQ), Bender-Gestalt Test (BGT), depression and anxiety scores), 
structural imaging findings (Computerized tomography (CT) scan, Magnetic 
Resonance Imaging (MRI), Diffusion Tensor Weighted Imaging (DTI)), 
Electroencephalography and Quality of life. 
4. To associate the type of structural lesions in MRI with the demographics, clinical 
characteristics, psychological assessment and EEG findings. 
5. To correlate side of abnormality across various neuroimaging investigation (CT, 
MRI, DTI) and EEG with the type of seizure. 
6. To assess the sensitivity of each imaging techniques (CT, MRI, and DTI) or in 


















4.1. Study design 
 A prospective study was carried out to investigate prevalence, demographics, 
clinical characteristics, psychological status, radio-imaging structural abnormalities and 
EEG in subjects with intractable epilepsy. Subjects who fulfilled the Drug resistant 
epilepsy criteria defined by ILAE were considered for the present study. A cohort of 600 
patients with intractable epilepsy was considered for data collection over a period of 3 
years from 21-09-11 to 20-09-14. Before the study Ethics Committee clearance was 
obtained from the local ethics committee in Madras Medical College (Letter No.  
40062011 dated 24-06-2011). Data collection was carried out after getting informed 
written consent (Tamil) from all participants.  
 
 The present study was carried out in four phases, 1) Screening for intractable 
epilepsy using Drug-resistant epilepsy criteria (ILAE, 2010), 2) Data collection from the 
previous medical records, case history and Neurological examination, 3) follow-up and 
review of patients after investigations (Imaging and interictal EEG recordings) and 4) 
follow-up and review of patients after neuropsychological assessment.  
 
Phase 1: During 3 years (from 21-09-11 to 20-09-14) at the epilepsy clinic, Institute of 
Neurology, Rajiv Gandhi Government Hospital, Chennai, a total of 2850 patients were 
screened to identify patients with intractable epilepsy who were fulfilling the ILAE 
criteria. Among the patients who fulfilled the inclusion and exclusion criteria, 600 
patients were randomly selected for data collection. 
 
Phase 2: All the participants underwent detailed data collection from previous medical 
records, case history, and Neurological examination. Medical records over the period 
ranging from 5 to 20 years were obtained from the patients. Case histories were obtained 
from the patient or caregivers with the procedure as mentioned in the methodology. Also, 
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all patients underwent a neurological examination under the direct supervision of the 
researcher himself. All the collected data were entered into a personal computer using  
software designed for entering the data as seen in Appendix 1. 
 
Phase 3: Following the neurological examination, the intractable epilepsy patients were 
referred to the radiology department for neuroimaging studies (CT, MRI, DTI and 
volumetric studies). The protocols used for each test were described in methodology. 
Interictal EEG recordings were done after neuroimaging investigations at our 
department. All the tests in phase 3 were carried out within 3 to 6 months after 
enrollment of each patient. All the patients were reviewed, and neuroimaging findings 
were entered into the computer.  
 
Phase 4: Neuropsychological evaluations (Intelligent Quotient (IQ), the mental quotient 
(MQ), Bender-Gestalt Test (BGT), anxiety and depression scales) were carried out by 
experienced clinical neuropsychologist within 2-3 months afterthe radiological 
investigation. Neuropsychological reports and data collected were entered into the 
computer, and all statistical analyses were carried out using the well-known statistical 
package IBM SPSS (version 21) software. 
 
4.2. Participants 
600 intractable epilepsy patients with the following inclusion and exclusion criteria were 
considered as a cohort group for the present study. 
 
4.2.1. Inclusion criteria 
1) Patients who fulfilled the criteria of Drug-resistant epilepsy defined by ILAE (2) 
were considered for the present study. 




4.2.2. Exclusion criteria  
1) Patients with poor drug compliance were excluded from the present study. 
2) Patients with alcohol addiction and substance abuse were not considered. 
3) Patients with psychogenic nonepileptic seizures were excluded. 
4) Patients with any other neurological illness were excluded. 
 
4.3. Material and Procedure 
4.3.1. Case history 
 Detailed Case history evaluation was done using direct one to one clinical 
interview and questionnaire. The software contained questionnaire containing a set of 
questions to collect information regarding demographic data, family history, prenatal, 
perinatal and postnatal history. The questionnaire was administered by the clinician to 
the patients or caregivers at the outpatient department in epilepsy clinic. If the patients 
have severe cognitive impairment, the questionnaire was administered to the caregivers. 
Demographic data included Patient’s record number, name, age, gender, address, contact 
number, educational status and occupational status. Under medical history, information 
regarding prenatal history, natal, post natal history, developmental history, family 
history, patient habits (alcohol, smoking, and substance abuse), sleep disturbance, 
behavioural changes, cognitive impairment and neuropsychological manifestations were 
collected. 
 
4.3.2. Neurological examination 
 Neurological examination included collecting information about seizure from 
previous medical records, semiology of seizures given by the patients or caregivers and 
direct observation of seizures by the examiner. The information collected includes data 
about Seizure type, onset of seizure, duration of seizure, Seizure semiology and its 
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changes, the presence of neurocutaneous markers, the frequency of seizures, clustering, 
precipitating factors, status epilepsies, hemiparesis, migraine and trauma.  
 
4.3.3. Neuroimaging investigations 
 Neuroimaging investigations included CT scan, MRI scan, diffusion tensor 
weighted imaging (DTI) and hippocampal volumetric studies. All the neuroimaging 
investigations were carried out by an experienced neuroradiologist and identified 
structural abnormalities in the brain. All CT, MRI, DTI and volumetric studies images 
and reports were collected and the informations were entered for the corresponding 
patients. Following protocols were used to collect data from each radiological 
investigation. 
 
4.3.3.1. CT scan protocol 
 All the subjects underwent conventional CT scan assessment using 16 slices CT 
scanner system (Siemens, Germany). Axial sections were taken using the following 
protocol: 1. Scout: Lat (Length 350) Breath Hold: None 2. Axial: 5mm x 5mm Recon: 
5mm x 5mm Bone 3. FOV: 250 4. Scan Length: angled to the base of the skull through 




4.3.3.2. MRI protocol 
 All the subjects underwent conventional MRI and DTI imaging on a 1.5T, 48 
Channel System (Siemens Aera, Germany) using a head coil (40 elements), Gradient 
strength of 45mT & flow rate of 200 Mt/sec. MRI protocol consisted of axial T1 
weighted sequence (T1), axial T2 weighted sequence (T2) and volumetric T1 weighted 
MRI (3D – SPGR) sequence208. These images were analysed by experienced 




4.3.3.3. DTWI and hippocampal volumetric study Protocol 
 DTWI was performed in the axial plane by using single-shot echo planar imaging 
with the following parameters: TR/TE - 3500/83 ms; diffusion-gradient encoding in 20 
directions; b0 - 1000 s/mm2; FOV - 230 X 100 mm; matrix size - 128 X 128; section 
thickness - 5 mm; bandwidth- 1500, EPI factor- 128 average - 3 and number of signals 
were acquired. Standard DTWI acquires data in three orthogonal planes (typically X, Y, 
and Z axis). 
 
 The acquisition was repeated with gradients oriented in each of the 3 directions in 
space. With 2 acquisitions with different b-factors (typically b = 0 and 1000 s/mm2), it 
becomes possible to calculate the apparent diffusion coefficient (ADC) without the T2. 
While ADC maps reveal the tendency of the water molecules to diffuse within a voxel, 
directional variation is also required to image 3D anisotropic diffusion. The complex 
mathematical equation used to model 3D anisotropy is called tensor. 
 
 By sampling a minimum of 6 or more diffusion directions and establishing a 
relationship between the acquired data and applied diffusion gradients in the pulse 
sequence, the directional variation in the tendency of water molecules to diffuse within a 
voxel was imaged. FA- fractional anisotropy, geometric tensor metrics (linear 
anisometry-Cl, planar anisometry Cp, and spherical anisometry- Cs), and ADC- apparent 
diffusion coefficient, RA- relative anisometry , GA- Geodesic anisometry were 
calculated by using the standard algorithms respectively. Images were transferred to a 
separate multi-modality workstation (Siemens MMWP) - Neuro 3D software for post 
processing. 
 
 In addition to the above, MR data was also obtained from a separate cohort of 
controls and patients on a 3T Siemens Spectra scanner: a T1 weighted structural axial 
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MPRAGE sequence was performed to obtain high-resolution structural data. The voxel 
dimensions were 0.98 mm x 0.98 mm x 1mm. DWI images with an isotropic voxel 
dimension of 2mm x 2mm x 2 mm were obtained with 64 gradient directions at a B value 
of 1000. Reference volumes with B = 0 were also obtained. 
 
 Maps of FA and ADC were calculated at the various region of interest especially 
in Frontotemporal fasciculus, frontoparietal fasciculus, temporoparietal fasciculus, 
temporo occipital fasciculus, parieto occipital fasciculus, uncinate fasciculus, 
hippocampal and parahippocampal region, fornix and fimbriae, cingulate gyrus to 
identify various tracts or regions which are involved in the maintenance of normal brain 
function. 
 
 Shape and position of the hippocampus were also carried out. These images were 
analyzed by experienced neuroradiologists who detected the MCDs and hippocampal 
malformations. The criteria for the incomplete hippocampal inversion (malrotation of the 
hippocampus) included incomplete rotation, the abnormal rounded appearance of the 
head of the hippocampus, blurry internal structure, changes in shape, size and vertical 
orientation of collateral sulcus. Patients fulfilling at least three criteria were identified as 
IHI. 
 
4.3.4. EEG investigations 
 Routine Scalp EEG recording was performed using Nicolet EEG system (Natus, 
USA) during the interictal period. Electrodes were placed on the scalp using 10-20 
classification systems. EEG was recorded using 25 channels. Waves were amplified and 
filtered with low pass filter with a high cutoff of 70Hz and high pass filter with a low 
cutoff of 1Hz. Sensitivity used was 70 microvolt/ cm with a time base of 30mm/sec. 
EEG was recorded during awake time, eye opening and eye closure, Photic stimulation, 
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sleep deprivation and hyperventilation. 
 
4.3.5. Neuropsychological Assessment 
 After neuroradiological investigations, the clinical neuropsychologist assessed 
the patients for psychological functions. Neuropsychologist was blinded to the type of 
structural abnormalities in the brain. All of the neuropsychological assessments were 
carried out in a quiet and well-lit room. Initially, Bender Gestalt Test (BGT) was 
administered. If patients were able to perform the task in BGT, the Intelligent Quotient 
(I.Q) and Memory Quotient (M.Q) assessment were carried out. If the I.Q was greater 
than 70, scales to evaluate anxiety, depression, and quality of life were administered. 
Whenever patients were not able to perform BGT or could not perform any task or low 
IQ less than 70, scales to evaluate anxiety and depression and quality of life scale was 
not administered. The following neuropsychological tools were used to assess each 
patient 1) Bender Gestalt test to assess visuoperceptual functions, 2) Weschler's children 
or adult intelligence scale to assess intelligence quotient, 3) Wechsler memory scale to 
assess the memory quotient 4) Multiphasic personality questionnaire to assess anxiety 
and depression and 5) WHO quality of life Brief (WHOQOL – BRIEF) questionnaire to 
assess quality of life. World health organisation quality of life scale was used to estimate 
the quality of life in 4 domains (physical health, psychological health, social relationship 
and the environment). Scores in each domain ranged from 0 to 100. 147 patients who had 
mental retardation were considered as having a poor quality of life. Scores less than or 
equal to 50 were considered as a poor quality of life and scored greater than 50 were 
considered as a good quality of life. Total quality of life scores ranged from 0 to 120. 
Scores were classified into 4 categories 1) very poor (mentally retarded group), 2) poor 





4.3.6. Statistical Analysis 
 Out of 600 patients with fulfilled the criteria for drug-resistant epilepsy (ILAE, 
2010) only 506 patient returned back with complete information regarding the medical 
history, neuroimaging reports, interictal EEG findings and neuropsychological 
assessment reports. Thus 506 patients with a complete set of data were included in the 
study for further analysis. The data collected from intractable epileptic patients were 
carefully coded and entered into a personal computer.  All statistical analyses were 
carried out using the specially designed statistical software package, IBM SPSS (Version 
21, 2014).  Some of the statistical analyses carried out for the present study include the 
formation of frequency tables – one-way, two-way and multiway - with percentages; 
summary statistics such as mean, standard deviation, etc. For qualitative data analyses, 
non-parametric tests and for quantitative data analysis parametric was used.  In all the 














5.1. Prevalence of intractable epilepsy 
 The present study estimated prevalence of intractable epilepsy using drug-
resistant epilepsy criteria (ILAE, 2010). Out of 2850 patients (1523 males and 1327 
females) seen at the epilepsy clinic, 600 (21.05%) patients fulfilled the criteria for drug-
resistant epilepsy. Patients who completed all the investigation were 506 patients -  294 
(58.1%) males and 212 (41.9%) females. From the present study at our epilepsy clinic, 
the prevalence of intractable epilepsy is reported to be 21.05 % that approximates 1 in 5 
patients with epilepsy are intractable to medical management.  
 
5.2. Demographics of patients with intractable epilepsy 
 Demographic details collected from patients with intractable epilepsy showed the 
distribution of patients across the age, gender, education and occupation as seen in 
Table-1. Most of the patients with intractable epilepsy were observed commonly in the 
age range of 16-20 years (24.11%), followed by 26-30 years age range (16.60%). 
Decreased prevalence was observed in the age range >60 years (1.38%).  
 
 Educational status of patients with intractable epilepsy shows most of the 
patient's literacy is high school level (38.54%) and elementary school level (32.21%). 
16.8% of them were illiterate and had no school education. Though major literacy level 
of patients with intractable epilepsy was high school and elementary level, high 
frequency of unemployment (36.96%, n= 187) was observed in patients with intractable 
epilepsy. Only a few proportion of the population were in skilled (13.24%), clerical 
(3.36%) and professional jobs (1.58%). A significant proportion of patients (13.64%) 
were underemployed and are working as a daily labourer.  14.62 % (n= 74) of females in 
the intractable epilepsy group were housewives.  
 
  
 Figure 3: Percentage of patients across duration of seizure 
 
 





















Table 1:Demographics of 506 patients with intractable epilepsy 
Demographics n % 
Age 
(in years) 
10-15 18 3.56 
16-20 122 24.11 
21-25 67 13.24 
26-30 84 16.60 
31-35 64 12.65 
36-40 54 10.67 
41-45 33 6.52 
46-50 21 4.15 
51-55 25 4.94 
56-60 11 2.17 
>60 7 1.38 
Gender 
Male 294 58.10 
Female 212 41.90 
Education level 
No school education 85 16.80 
Elementary (1-8) 163 32.21 
High school (9-12) 195 38.54 
Graduate 63 12.45 
Occupational status 
Unemployed 187 36.96 
Housewife 74 14.62 
Daily laborer 69 13.64 
Skilled 67 13.24 
Clerical 17 3.36 
Professional 8 1.58 
Student 70 13.83 
Dependent 14 2.77 
 
 
5.3. Clinical characteristics of patients with intractable epilepsy 
5.3.1. Type of seizure 
 The major type of seizure that caused intractability is partial seizures (72.92%, 
n=369) followed by generalized seizures (27.08%, n=137). In partial seizures, 319 
patients had complex partial seizures, 50 patients had a simple partial seizure, and 7 had 
mixed type of seizures which constitute 63.04%, 9.88% and 1.38% of the total patients 
with intractable epilepsy respectively. In generalised epilepsy, 121 patients had 
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generalised tonic clonic seizures and 16 patients had myoclonic epilepsy which 
constitutes 23.91% and 3.16% of the total patients with intractable epilepsy. In the 
present series of 506 patients, we could not observe any patients with absence seizures as 
seen in Table 2.  
 
5.3.2. Duration of seizures 
 Most of the patients (77.07%) in the present study had seizure duration ranging 
from 1-20 years as seen in table 2. Seizure duration (greater than 21 years) was observed 
in less proportion of patients (22.92%) with intractable epilepsy as seen in figure 3.  
 
5.3.3. Onset of seizures 
 From the present study, it was observed that most of the patients who had 
intractable epilepsy had early onset of seizure i.e., less than 5 years of age (30.24%, 
n=153).  The age of onset of seizures decreased with increase in age range as seen in 
Table 2. The number of patients decreased as the age of seizure onset increased as seen 
in figure 4. 
 
5.3.4. Seizure frequency 
 Most of the patients with intractable epilepsy had seizure frequency of 1-4 
episodes per month (54.35%, n=275), followed by 1-6 episodes per week (29.84%, 
n=151) and daily occurrence (15.81%, n=80) as seen in Table 2. 
 
5.3.5. Seizure semiology 
 The change in seizure semiology was observed from the clinical records. The 
most frequently observed change was from generalised to complex partial seizures and 
also from simple partial to complex partial seizures observed in 329 patients (65.02%) as 
seen in Table 2. The changes in seizure semiology happened 1-5years after the onset of 
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an initial episode of seizure. Out 319 patients with CPS 20% of them had initial seizure 
semiology of partial seizure (64/319) and 47% of them had initial seizure semiology of 
generalised seizure (150/319). 
 
Table 2: Clinical characteristics of 506 patients with intractable epilepsy 
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 Clustering of seizures was not observed in 296 patients (58.5%) with intractable 
epilepsy. Clustering was reported to be present for 1-2 times in 145 patients (28.66%), 2-
3 times in 44 patients (8.70%) and greater than three times in 21 patients (4.15%) as seen 
in Table 2. 
Table 3: Medical history in 506 patients with intractable epilepsy 
 
Medical history n % 
Developmental milestones 
Normal 433 85.57 
Delayed 73 14.43 
Natal history 
Not significant 474 93.68 
LSCS 11 2.17 
Asphyxia 21 4.15 
Postnatal history 
Not significant 478 94.47 
Infections 6 1.19 
Head injury 5 .99 
Stroke 3 .59 
Febrile seizures 10 1.98 
Hypothyroidism 4 .79 
Family history 
Absent 472 93.28 
Present 34 6.72 
Precipitating factor 
Not significant 381 75.30 
Sleep deprivation 78 15.42 
Febrile illness 10 1.98 
Nocturnal 16 3.16 
Others 21 4.15 
Neuroexamination 
Not significant 378 74.70 
Headache 101 19.96 
Stroke 17 3.36 
Neurocutaneousmarkers 10 1.98 
Comorbid conditions 
Not significant 420 83.00 
Migraine 71 14.03 
Head trauma 12 2.37 





5.3.7. Precipitating factors 
 Many patients in the present study population had sleep deprivation as 
precipitating factor (15.42%, n=78), followed by other factors like menstruation (4.15%, 
n=21) including sleep (3.16%, n=16) and febrile illness (1.98%, n=10). Precipitating 
factors for epilepsy were not reported by patients or caregivers in 75.30% of the 
population (n=381) as seen in Table 3. Other precipitating factors include loud sounds 
and light (cinema, watching TV and working as a welder). 
 
5.3.8. Status epilepsy 
 Status epilepsy was reported in 42 patients (8.30%) of the population as seen in 
Table 2. 
 
5.3.9. Drugs  
 Most of the patients with intractable epilepsy were under polytherapy (84.78%, 
n=429). 15.22% (n=77) of them were under monotherapy as seen in Table 2. All the 
patients were treated with one or more of the following drugs (carbamazepine, sodium 
valproate, phenobarbitone, and phenytoin sodium). 
 
5.3.10. Co-morbid conditions 
 The major comorbidity of epilepsy in the present study was a migraine which 
accounted for 14.03% (n=71), followed by stroke (3.36%, n=17), head injury (2.37%, 
n=12) and smoking (<1%) as seen in Table 3.  
 
5.3.11. Medical history 
 Medical history findings in 506 patients with intractable epilepsy were 
summarised in Table 3. In the birth history, asphyxia was reported to be present in 4.15% 
(n= 21) of the population. Postnatal febrile seizures were observed in 1.98% (n=10), 
  
Figure 5: A 16-year-old male with hemimegaloencephaly and hypomelanosis of ito 
 
  
Figure 6: A 32-year-old male with 
adenoma sebaceum 
Figure 7: A 30-year-old male with 








followed by 6 patients (1.19%) with infections, 5 patients (0.99%) with a head injury, 
and 4 patients (0.79%) with hypothyroidism and 3 patients (n=3) with infantile stroke. 
Delayed motor developmental milestones were reported to be present in 73 patients that 
constitute 14.43% of the population as seen in Table 3. 
 
5.3.12. Family history 
 Positive family history for seizures was reported in 34 patients (6.72%) of the 
population studied as seen in table 3. 
 
5.3.13. Neurocutaneous markers 
 Neurocutaneous markers like adenoma sebaceum, hypomelanosis of ito, 
neurofibromatosis and sturge weber syndrome were observed in the present case series 
as seen in Table 3. A total 10 patients with intractable epilepsy (1.98%) had 
neurocutaneous markers and associated structural abnormalities in the brain. 6 patients 
with adenoma sebaceum, 2 patients with neurofibromatosis, one patient with 
hypomelanosis of ito, and one with Sturge-Weber syndrome. The images of the 
neurocutaneous markers observed are shown in figure (5-8).  
 
5.3.14. Neurological investigation  
 During the neurological investigation, the headache was often reported by the 
patients with epilepsy (19.96%, n=101) followed by hemiparesis (.98%, n=5) as seen in 
Table 3. 
 
5.3.15. Electroencephalography findings 
 Interictal EEG showed generalised epileptiform discharges in 40.71% (n=206) of 
the total population. Focal epileptiform discharges were observed in 80 patients 
(15.81%) with intractable epilepsy. Out of 80 patients with focal EEG activity, 25 
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patients were from the right hemisphere and 55 patients from the left hemisphere. 220 
patients (43.48%) in spite of their seizure intractability, showed normal interictal EEG 
findings as seen in Table 4. 
 
Table 4: Interictal EEG findings in 506 patients with intractable epilepsy 
Interictal EEG findings n % 
EEG 
Normal 220 43.48 
Focal 80 15.81 
Generalised 206 40.71 
Side of lesion - EEG 
Right 25 4.94 
Left 55 10.87 
Bilateral 206 40.71 
Non-significant 220 43.48 
 
5.4. Neuroimaging results in patients with intractable epilepsy 
5.4.1. CT scan findings 
 In the present study, several neuroimaging investigations were carried out 
systematically to evaluate lesions in the brain among patients with intractable epilepsy. 
388 (76.68%) patients with intractable epilepsy did not show significant abnormalities of 
the brain in CT scan. The lesions most commonly observed in participants with 
intractable epilepsy were calcification (10.47%, n=53), followed by atrophy (5.34%, 
n=27), gliosis (4.15%, n=21) and infarction (1.98%, n=10). Non-neoplastic cysts, 
neoplasms and lissencephaly were rarely observed in patients with intractable epilepsy in 
CT imaging. The majority of lesions were bilateral (12.06%, n=61) especially 
calcifications. Following bilateral lesions, left sided lesion were more common than 





Table 5: Structural abnormalities in patients with intractable epilepsy  
















































































































 Figure 9: MRI brain (T2 image) of 50-year-old female showing features of left mesial 
temporal sclerosis. DTI images showing altered fractional anisotropy (FA), Mean 
Diffusivity (MD) in the left side 
 
 
Figure 10: MRI brain of 32-year-old male with moderate atrophy of right hippocampus 
head, body, and tail with internal T2 hyperintense signal - showing features of right 
mesial temporal sclerosis 
 
 
Figure 11: MRI brain of 12-year-old female with bilateral hippocampal atrophy showing 




5.4.2. MRI findings  
 Most common abnormality (32.02%, n=162) that was observed in patients with 
intractable epilepsy was Mesial temporal sclerosis (MTS). Following MTS, non-specific 
lesions that include cortical atrophy, periventricular white matter calcifications were 
commonly observed in 15.61% (n=79) of the population. Neoplastic and nonneoplastic 
lesions including gliosis, cyst, vascular malformations, haemorrhage and infective 
lesions were observed in 12.06% (n=61%). Malformations of cortical development were 
observed in 9.88% (n=50) of patients with intractable epilepsy. Incomplete hippocampal 
inversion was observed in 35 patients with intractable epilepsy that constitute 6.92% of 
the total population studied. Frequently, lesions were observed on the left side (35.57%, 
n=180) when compared to bilateral (23.52%, n=119) and right-sided lesions (17.39, 
n=88). 119 (23.52%) patients with intractable epilepsy did not show any abnormalities in 
1.5Tesla MRI. Various abnormalities in MRI were summarised in Table 5. 
 
5.4.2.1. Mesial temporal lobe sclerosis  
 Mesial temporal sclerosis was most commonly observed in the left side (18.37%, 
n=93) compared to the right side (8.30%, n=42). Bilateral MTS was observed in 27 
patients (5.33%). Also, MTS was associated with malformation of cortical development, 
gliosis, nonspecific cystic lesions, infarction, and incomplete hippocampal inversion in 
28 patients (5. 53%).These lesions were categorised under multiple lesions as seen in 
Table 6. Patients with left MTS, right MTS, and bilateral MTS were shown in figure 9, 






Figure 12: MRI brain (Flair) of 42 years old female showing focal cortical dysplasia in 






Figure 13: MRI brain (Flair) of an 18-year-old male showing focal cortical dysplasia 





Table 6: Multiple lesions associated with MTS 
Multiple lesions n % 
MTS  and  Gliosis 11 2.17 
MTS and Non-specific cystic lesion 9 1.78 
MTS and Incomplete hippocampal inversion 2 .40 
MTS and Malformation cortical development 5 .98 
MTS and Infarction 1 .20 
 
5.4.2.2. Malformations of cortical development  
 Several malformations of cortical development were observed in 506 patients 
with intractable epilepsy. MCD were grouped into the following categories as 
summarised in Table 7. 
 
5.4.2.2.1. Focal cortical dysplasia 
 Most commonly observed malformation of cortical development is focal cortical 
dysplasia (5.13%) in the series of 506 patients with intractable epilepsy. Focal cortical 
dysplasias (FCD) were observed commonly in temporal and frontal lobes especially on 
the left hemisphere as seen in Table 7. Also, there were few patients with FCD in 
parietal and occipital lobes. 5 patients in the FCD group had multiple focal thickening of 
various lobes in the brain.  MRI brain images of 2 patients with FCD are shown in figure 
12 & 13.  
 
  
         
 
 
Figure 14: 16 year old twins with polymicrogyria -diffuse cortical thickening of 
bilateral temporooccipetal region, Vertical orientation of body and tail of left 
hippocampus, pontine hypoplasia, posteriorly pointing dense with left cerebellar 
tonsillar herniation and crowding of foramen magnum. 
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Table 7:Various malformation of cortical development observed in 506 patients with 
intractable epilepsy 
Various Malformation of 
cortical development 
Frequency (n=50) Percentage 
Focal cortical dysplasia 
Frontal lobe                       Right  
                                           Left 
                                           Bilateral 
Temporal lobe                   Right 
                                           Left 
                                           Bilateral 
Parietal lobe                       Right 
                                           Left 
                                           Bilateral 
Occipital lobe                    Right 
                                           Left 


























Pachygyria 1 .19 
Polymicrogyria 2 .39 
Dysembryonic neuroepithelial tumor 2 .39 
Heterotopia 4 .79 
Lissencephaly 2 .39 
Schizencephaly 2 .39 
Hemi- megalenchephaly 1 .19 
Multiple pathologies 10 1.97 
Agenesis of body and tail of caudate nucleus 1 .19 
 
5.4.2.2.2. Polymicrogyria  
 Polymicrogyria (PMG) was observed in 2 patients. Both the patients were 16-
year-old female twins. Both of them had polymicrogyria as evidenced by diffuse cortical 
thickening of bilateral temporo occipital region with a paucity of sulcation and poor grey 
and white matter differentiation. The vertical orientation of body and tail of left 
 
Figure 15: MRI brain of 23-year-old female showing DNET tumor in the left 
parasagittal frontal region 
 
 
Figure 16: MRI brain of 33year old male with bilateral subependymal nodular 
heterotopia along the lateral ventricles and transmantle heterotopia along the left 




Figure 17: MRI brain of 15-year-old male showing Subcortical band heterotopia or 
double cortex syndrome 
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hippocampus, pontine hypoplasia, posteriorly pointing dense with left cerebellar 
tonsillar herniation causing crowding at foramen magnum were also observed in both 
the twin patients. MRI brain images of a twin with polymicrogyria are shown in  
figure- 14.  
 
5.4.2.2.3. Pachygyria 
 One patient had bilateral pachygyria over the parietal lobe.  
 
5.4.2.2.4. Dysembryonic neuroepithelial tumor 
 DNET tumors were observed in two patients. MRI brain of a 23-year-old female 
with DNET tumor in the left parasagittal frontal region is shown in figure 15.  
 
5.4.2.2.5. Heterotopias 
 Heterotopias were observed in 4 patients with MCDs. MRI brain of 33year old 
male with bilateral subependymal nodular heterotopia along the lateral ventricles and 
transmantle hetero topiae at left superior frontal sulcus is shown in figure 16. Also, MRI 
brain of a 15-year-old male showing Subcortical band heterotopia or double cortex 
syndrome is shown in figure 17. A 26-year-old male with bilateral subcortical 
heterotopia in MRI is shown in figure 18 
 
5.4.2.2.6. Lissencephaly  
 Lissencephaly was present in 2 patients.These patients are suffering from 
intractable epilepsy characterised by complex partial seizure of extra temporal origin 
often precipitated by loud sounds with initial generalised myoclonus and mental 
retardation. MRI brain of 16-year-old male with lissencephaly is shown in figure 19. 
  
 Figure 18: MRI brain of 26year old male with bilateral subcortical lesion (heterotopia) 
 
 
Figure19: MRI brain of 16-year-old male showing lissencephaly 
 
 






 Schizencephaly were observed in 2 patients. One patient had open lip 
schizencephaly, and other had closed type. The cleft in schizencephaly was observed in 
the parietal region. MRI brain images of 12-year-old male and a 44-year-old male with 
the open and closed type of schizencephaly were seen in figure 20 and 21 respectively. 
 
5.4.2.2.8. Hemimegalencephaly 
 Hemimegalencephaly was observed in one patient in the right hemisphere. 
Neurocutaneous markers (hypomelanosis of ito) was observed in this patient over the 
shoulder, trunk, and back of the right arm. MRI brain of 16-year-old male with Right 
sided hemimegalencephaly, and hypomelanosis of ito is shown in figure 22. 
 
5.4.2.2.9. Agenesis of body and tail of caudate nucleus 
 Agenesis of body and tail of caudate nucleus were observed in 1 patient 
 
5.4.2.2.10. Multiple pathologies 
 Following FCD, most common abnormalities observed were multiple 
pathologies. Commonly FCDs were observed with hippocampal sclerosis (dual 
pathology) in five patients, hippocampal malrotation was observed with FCD and 
ependymal nodules in three patients indicating features of tuberous sclerosis complex. 
Monozygotic twins showing multiple lesions were observed in the present study. Both 
the females patients had bilateral temporo occipital PMG, pontine hypoplasia, and 
posteriorly pointing dense with left cerebellar tonsillar herniation 8mm below the 
foramen magnum.  
  
  





Figure 22: MRI brain of 16-year-old male with Right side hemimegaloencephaly and 




5.4.2.3. Incomplete hippocampal Inversion  
 Hippocampal malrotation or incomplete hippocampal inversion (IHI) were 
identified in a small proportion of patients with intractable epilepsy using hippocampal 
volumetric studies. Out of 509 patients, 35 patients had incomplete hippocampal 
inversion which constitutes 6.92% of the total population. IHI was commonly observed 
in left hippocampus (n=30) compared to the right hippocampus (n=5). Three patients 
who had IHI also presented with FCD were categorised under multiple pathologies. MRI 
brain showing left IHI and FCD with right IHI are shown in figure 23 and 24. 
 
5.4.2.4. Neoplastic and nonneoplastic lesions  
5.4.2.4.1. Neoplasms 
 Neoplastic lesions were observed in two patients. One patient with glioma and 
another patient with Gliomatosis cerebri. MRI Brain of a 30-year-old male showing 
glioma in the left temporal region is shown in figure 25. 
 
5.4.2.4.2. Inflammation 
 Inflammation and Infections like herpes simplex encephalitis with granuloma (1 
patient), tuberculous meningoencephalitis (1 patient), neurocysticercosis (1 patient), 
Hashimoto’s autoimmune encephalitis (1 patient) and Rasmussen's encephalitis (1 
patient) were observed in 5 patients with intractable epilepsy.  MRI brain images of 
patients with herpes simplex infection, neurocysticercosis, autoimmune encephalitis and 
Rasmussen's encephalitis are shown in figure 2,27, 28 and 29 respectively. 
 
5.4.2.4.3. Gliosis  
 Gliosis at various regions of the brain especially parieto occipital and 
orbitofrontal regions was observed in 29 patients (5.70%) with intractable epilepsy 
signifying nonspecific lesion secondary to trauma, ischemia and inflammation. 
 Figure 23: MRI brain showing normal hippocampus (Left side) and Left incomplete 
hippocampal inversion (Right side) 
 
 
Figure 24: MRI brain (T1 Flair) of 24-year-old male showing Left parietal FCD and 
Right sided incomplete hippocampal inversion 
 
 
Figure 25: MRI Brain of 30-year-old male showing glioma in left temporal region 
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Intractable epilepsy associated with infarctions was observed in 12 patients (2.37%). 
Most of the patients had infarction at the left hemisphere, especially in the 
parietooccipital region. MRI brain of a 40-year-old male with left parieto occipital lobe 
infarction and gliosis is shown in figure 30. 
 
5.4.2.4.4. Non-neoplastic cysts 
 Non-neoplastic cysts were observed in 5 patients with intractable epilepsy 
(0.98%). T1 weighted images (MRI brain) of a 36year old male with a cystic lesion in 
right medial temporal region is shown in figure 31. 
 
5.4.2.4.5. Arteriovenous malformation 
 Arteriovenous malformation (AVM) was associated with focal intractable 
epilepsy with secondary generalisation in 6 patients (1.18%). All of them had AVM at 
Parieto temporal region.2 patients with intractable epilepsy presented with haemorrhage 
in the brain (0.39%). Figure 32 shows MRI (brain) of a 27-year-old female with left 
Parietal Arteriovenous malformation, left parietal gliosis and atrophic changes. 
 
5.4.2.5. Non-specific lesions  
 Idiopathic focal cortical atrophy was observed in 11 patients (2.2%). 
Calcification (focal calcification, multiple calcifications (small and large)), calcification 
with gliosis and calcifications with perilesional edema were observed in 68 patients 
(13.43%). MRI (brain) of a 36-year-old male with cavernous hemangioma in right 
medial temporal region is shown in figure 33. Figure 34 shows X-ray (skull), CT scan 
(brain), and MRI (brain) of a 21-year-old male with large calcification and gliosis at the 
left Parietal region. A 55year old female with bilateral Subcorticalcalcifications with 
thyroidectomy scar is shown in figure 35. MRI images of patients with focal 
calcifications and multiple calcifications are shown in figure 36 and 37 respectively 
 Figure 26: MRI brain (contrast) of a 16year old female with herpes simplex infection & 









Figure 28: MRI brain of a 15-year-old male with autoimmune encephalitis showing 
inflammation over the left parietooccipital region. 
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Table 8: Number of patients with abnormal ADC and FA values in DTWI across 
various regions of interest 
 
Regions of interest 
No. of patients 
(N=506) 
 
Hippocampal and parahippocampal region 
Middle cerebellar peduncle  
Uncinate fasciculus  
Frontotemporal fasciculus  
Frontoparietal fasciculus  
Temporoparietal fasciculus  
Temporooccipital fasciculus  
Parietooccipital fasciculus  
Fornix  
Fimbriae  
Cingulate gyrus  
Thalamus  

















5.4.3. DTWI findings 
 Diffusion tensor weighted images (DTI) showed increased FA (fractional 
anisotropy) values and decreased ADC (apparent diffusion coefficient) values in one or 
several regions in the brain among the various regions of interest considered for the 
present study.  DTI were significantly abnormal in 406 (80.23%) intractable epilepsy 
patients. Of these patients, 158 (31.23%) patients showed left sided abnormality 
followed by bilateral (30.24%) and right sided (17.39%) abnormality. The areas of 
interest considered for the present study were frontotemporal fasciculus, frontoparietal 
fasciculus, temporoparietal fasciculus, temporo occipital fasciculus, parieto occipital 
fasciculus, uncinate fasciculus, hippocampal and parahippocampal region, thalamus, 
corpus callosum, fornix and fimbriae and cingulate gyrus. 217 patients especially 
 








patients with MTS showed abnormal DTI values in hippocampal and parahippocampal 
regions. Abnormal ADC and FA values were observed in higher frequencies at middle 
cerebellar peduncle, uncinate fasciculus, temporo occipital fasciculus, temporoparietal 
fasciculus, fimbriae, fornix, thalamus and corpus callosum. The involvement of 
cingulate gyrus,  parieto occipital fasciculus, frontoparietal fasciculus was less 
commonly observed in patients with intractable epilepsy as seen in Table 8.  
 
5.5. Neuropsychological assessment findings in patients with intractable epilepsy 
 Wechsler’s intelligence scale classified I.Q. scores into 1) mental retardation, 2) 
dull normal slow learners and 3) average intelligence. Wechsler’s Memory scale 
classified M.Q. scores into 1) normal and 2) deficits of memory dysfunction. Out of 506 
patients with intractable epilepsy, 147 patients (29.05%) had mental retardation (<69) 
score in Wechsler intelligence scale. 20% (n=104) of them had dull normal intelligence. 
255 patients (50%) of them had average intelligence. Wechsler memory quotient scores 
were low (<70) in 194 patients (38.34%) and showed memory dysfunction. Bender 
Gestalt test revealed abnormal visuoperceptual gestalt functions in 218 patients 
(43.08%). Multiphasic personality questionnaire to assess anxiety and depression could 
not be administered in 147 patients who had mental retardation. Multiphasic personality 
questionnaire administered to patients without mental retardation showed anxiety in 161 
patients (31.82%), depression in 142 patients (28.06%) and mixed anxiety and 
depression in 126 patients (24.90%) as seen in Table 9.  
  
 Figure 31: MRI Brain – T1 weighted images of a 36year old male with a cystic lesion in 




Figure 32: MRI (brain) of a 27-year-old female with left Parietal Arteriovenous 









Table 9: Neuropsychological findings in patients with intractable epilepsy 
Neuropsychological assessment n % 
IQ 
≤ 69: Mental retardation 147 29.05 
70 - 90: Dull normal slow learners 104 20.55 
> 90: Average intelligence 255 50.40 
MQ 
≥ 70:  Normal 312 61.66 
< 70:  Deficits of memory dysfunction 194 38.34 
BGT 
Normal 288 56.92 
Abnormal 218 43.08 
Anxiety 
Absent 198 39.13 
Present 161 31.82 
CNT 147 29.05 
Depression 
Absent 217 42.89 
Present 142 28.06 
CNT 147 29.05 
Anxiety and Depression 
Absent 233 46.05 
Present 126 24.90 
CNT 147 29.05 
CNT: could not test 
 
 A Higher proportion of intractable epilepsy patients had a poor quality of life in a 
social relationship (36.17%) followed by psychological health, environment and 
physical health domains as seen in Table 10. Most of the patients with intractable 
epilepsy had a poor and very poor quality of life scores in all the four domains as seen in 
Table 10. 
  
 Figure 34: X-ray (skull), CT scan (brain), and MRI (brain) from left to right of a 21year 
old male with large calcification and gliosis at the left Parietal region. 
 
 
Figure 35: MRI brain of a 55year old female with bilateral subcortical calcification 




Figure 36: CT Brain (right) and MRI brain(left) images of 13-year-old male with 
calcification in the right posterior parietooccipital region 
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Table 10: WHO Quality of life scores in 506 patients with intractable epilepsy 
Domains n % 
Physical Health 
Very Poor 147 29.05 
Poor 97 19.17 
Good 262 51.78 
Psychological Health 
Very Poor 147 29.05 
Poor 143 28.26 
Good 216 42.69 
Social Relationship 
Very Poor 147 29.05 
Poor 183 36.17 
Good 176 34.78 
Environment 
Very Poor 147 29.05 
Poor 101 19.96 
Good 258 50.99 
Total Quality of Life 
Very Poor 147 29.05 
Poor 50 9.88 
Average 215 42.49 
Good 94 18.58 
 
5.6. Comparison of the type of seizure with demographics, clinical 
characteristics, structural imaging and neuropsychological assessment findings 
of intractable epilepsy 
 
 Pearson’s Chi-square test was applied to the data to find an association between 
the type of seizures with the demographics, clinical characteristics, structural imaging 
and neuropsychological findings. Pearson’s chi-square test revealed a significant 
association between the patient age group and type of seizure. Generalised seizures were 
significantly (p<0.05) associated with 16-20 years, 26-30 years and 31-35 years age 
groups. The partial type of seizures had a strong association (p<0.05) with age ranges 
between 16 years to 40 years as seen in Table 11. 
 
 No significant association (p>0.05) was observed between the type of seizure and 






Figure 37: CT (Brain) of 41-year-old female with multiple calcification  
and perilesional edema 
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Clinical characteristics (developmental history, natal history, postnatal history, family 
history, the age of onset, duration of seizure, seizure frequency, precipitating factors, 
status epilepsy, comorbid conditions, and Drugs did not show any association with the 
type of seizure in the present population.  In 58% of patients with intractable epilepsy 
irrespective of the types of seizure did not show any clustering of seizure (p<0.05). But a 
few proportion of patients (25%, n=127) in partial seizure group had a significant 
association with the clustering of 1-2 times as seen in Table 12 . In the neurological 
examination, none of the comorbid conditions except a headache had an association with 
the type of seizures. Partial seizures had a strong association with a headache in 23.31% 
of the population (p<0.05). Seizure semiology change was observed significantly in a 
high proportion (68.02%) of patients with partial seizures followed by generalised 
seizure (56.93%). No change in seizure semiology was observed among 43.07% of 
patients in generalised seizure and 31.98% patients with partial seizures which were also 
statistically significant (p<0.05) as seen in Table 12.  
 
Table 11: Association of age and seizure type 
 
Demographics 
Seizure type Pearson’s Chi-
Square Test Generalised Partial seizure 
n % n % Value Sig. 
Age 
10-15 9 6.57 9 2.44 
22.618 0.012 
16-20 40 29.20* 82 22.22* 
21-25 10 7.30 57 15.45* 
26-30 17 12.41* 67 18.16* 
31-35 19 13.87* 45 12.20* 
36-40 9 6.57 45 12.20* 
41-45 11 8.03 22 5.96 
46-50 6 4.38 15 4.07 
51-55 11 8.03 14 3.79 
56-60 2 1.46 9 2.44 
>60 3 2.19 4 1.08 




Table 12: Comparison of clinical characteristics between generalise and partial seizures 
 
*level of significance <.05 
 
 CT scan findings did not reveal significant results with both type of seizures 
(p<0.05). Both types of seizures showed strong association with MTS, neoplastic and 
nonneoplastic lesions (gliosis, cyst, vascular malformation and infectious) and non-
specific lesions (p<0.05). 39.02% of patients with partial seizures were significantly 
associated with MTS when compared to generalised seizures (13.14%). 19.71% of 
patients with generalised seizures had non-specific lesions when compared to 14.09% of 
patients with partial seizures. Neoplastic and nonneoplastic lesions were observed 
almost in equal proportion among patients with generalised (13.87%) and partial 
seizures (11.38%) as seen in Table 6. 38.69% patients with generalised seizures had 
statistically significant normal MRI findings. DTI findings showed the significantly 
higher proportion of abnormalities in 85.09% of patients with complex partial 
seizures followed by 67.15% of patients with generalised seizures. DTI findings were 







seizure value sig 
n % n % 
Clustering of 
present seizure 
0 102 74.45* 194 52.57* 
24.782 0.000 
1-2 18 13.14 127 34.42* 
2-3 13 9.49 31 8.40 
>3 4 2.92 17 4.61 
Neuro 
examination 
Not significant 113 82.48* 265 71.82* 
11.935 0.008 
Headache 15 10.95 86 23.31* 
Hemiparesis 4 2.92 13 3.52 
Neurocutaneousmarkers 5 3.65 5 1.36 
Semiology  
change 
No change 59 43.07* 118 31.98* 5.400 0.020 
Change 78 56.93* 251 68.02*   
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in only 14.91% of patients with partial seizures which was not statistically significant as 
seen in Table 6. Interictal EEG findings were significantly normal in both the type of 
seizures (p<0.05). 49.64% patients with generalised seizures and 41.19% with partial 
seizures had normal EEG results. Focal epileptiform discharges were seen in 20.05% of 
patients with partial seizures. Focal epileptiform discharges were rarely observed 
(4.38%) in patients with generalized seizures. 45.99% of patients with generalized 
epilepsy had bilateral epileptiform generalized discharges followed by 38.75% of 
patients with partial seizures as seen in Table 13. 
 




Square Test Generalized 
Partial 
seizure 
n % n % Value Sig. 
CT Scan 
findings 
Not significant 97 70.80 291 78.86 
8.835 0.265 
Calcification 16 11.68 37 10.03 
Infarction 3 2.19 7 1.90 
Gliosis 9 6.57 12 3.25 
Atrophy 9 6.57 18 4.88 
Lissenchephaly 1 .73 0 .00 
Neoplastic 0 .00 2 .54 
Non-neoplastic 2 1.46 2 .54 
MRI 
findings 
Normal 53 38.69* 66 17.89 
43.127 0.000 
MCD 10 7.30 40 10.84 
MTS 18 13.14* 144 39.02* 
IHI 10 7.30 25 6.78 
Neoplastic and Non neoplastic 
lesions (gliosis, cyst, vasclar 
malform,infectious) 
19 13.87* 42 11.38* 
Nonspecific lesion (cortical 
atropy, periventcular white 
matter, calcification) 
27 19.71* 52 14.09* 
DTWI 
findings 
Normal 45 32.85* 55 14.91 
20.281 0.000 
Abnormal 92 67.15* 314 85.09* 
EEG 
findings 
Normal 68 49.64* 152 41.19* 
18.447 0.000 Focal 6 4.38 74 20.05* 
Generalised 63 45.99* 143 38.75* 




 Neuropsychiatry findings and type of seizures were compared using Pearson's 
Chi- Square test. Comparatively, a similar proportion of patients with the generalized 
seizure and partial seizure had low IQ and mentally retarded, reduced MQ, 
abnormalities in BGT, anxiety and depression and quality of life. Pearson's Chi-Square 
test did not reveal any significant difference between the IQ, MQ, BGT, anxiety, 
depression and quality of life scores between the generalised and partial seizures as seen 
in Table 14. 
 
Table 14: IQ, MQ, BGT, anxiety, depression and quality of life scores in different type 





Square Test Generalized 
Partial 
seizure 
n % n % Value Sig. 
IQ 
≤ 69 : Mental retardation 40 29.20 107 29.00 
2.553 0.279 
70 - 90: Dull normal slow 
learners 
22 16.06 82 22.22 
> 90: Average intelligence 75 54.74 180 48.78 
MQ 
≥ 70:  Normal 88 64.23 224 60.70 
0.526 0.468 < 70:  Deficits of memory 
dysfunction 
49 35.77 145 39.30 
BGT 
Normal 77 56.20 211 57.18 
0.039 0.844 
Abnormal 60 43.80 158 42.82 
Anxiety 
Absent 63 45.99 135 36.59 
5.151 0.076 Present 34 24.82 127 34.42 
CNT 40 29.20 107 29.00 
Depression 
Absent 67 48.91 150 40.65 
4.133 0.127 Present 30 21.90 112 30.35 
CNT 40 29.20 107 29.00 
Anxiety and 
Depression 
Absent 71 51.82 162 43.90 
4.010 0.135 Present 26 18.98 100 27.10 
CNT 40 29.20 107 29.00 
Total Quality 
of Life 
Very poor 40 9.49 37 10.03 
2.330 0.507 
Poor 13 38.69 162 43.90 
Average 53 22.63 63 17.07 





5.7. Association of type of structural lesions with demographics, clinical 
characteristics, neuro radio imaging and neuropsychological findings  
 
5.7.1. Structural abnormalities and their demographics in intractable epilepsy 
 Patients with structural abnormalities and without structural abnormalities were 
compared to find the association with demographic details. There was no association 
observed between the type of structural lesion and the demographics such as age, 
education level and occupational status except gender (p>0.05) as seen in the table. Male 
patients being more in the present study population showed a significant increase in the 
frequency of structural lesions as seen in Table 15. 
 
5.7.2. Clinical characteristics of structural abnormalities in intractable epilepsy 
 There was no significant association between the structural abnormalities and the 
clinical characteristics (medical history and seizure characteristics) of intractable 
epilepsy patients. The clinical characteristics associated with structural lesions were 
natal, postnatal, developmental and family history, seizure type, onset of seizure, 
duration of seizure, seizure semiology changes, neurocutaneous markers, frequency of 
seizure, clustering, precipitating factors, status epilepsies, neurological examination, 
comorbid conditions, and drugs. Even though there were significant p values in 
neurocutaneous markers, family history, the age of onset of a seizures, clustering, 
neurological examination and comorbid conditions using chi-square test, many of the 






Table 15: Association of demographics with structural abnormalities in brain 
Demographic  
variables 
























n Row % n Row % Value Sig. 
Age 




16-20 28 22.95 18 14.75 38 31.15 16 13.11 10 8.20 12 9.84 
21-25 16 23.88 5 7.46 20 29.85 1 1.49 6 8.96 19 28.36 
26-30 16 19.05 11 13.10 29 34.52 5 5.95 12 14.29 11 13.10 
31-35 14 21.88 3 4.69 24 37.50 6 9.38 7 10.94 10 15.63 
36-40 13 24.07 7 12.96 21 38.89 2 3.70 4 7.41 7 12.96 
41-45 6 18.18 1 3.03 14 42.42 1 3.03 3 9.09 8 24.24 
46-50 4 19.05 0 .00 9 42.86 1 4.76 5 23.81 2 9.52 
51-55 12 48.00 1 4.00 3 12.00 0 .00 3 12.00 6 24.00 
56-60 4 36.36 1 9.09 1 9.09 1 9.09 3 27.27 1 9.09 
>60 1 14.29 0 .00 1 14.29 0 .00 4 57.14 1 14.29 
Gender 
Male 66 22.45 31 10.54 88 29.93 16 5.44 50 17.01 43 14.63 
18.520 .002 









34 20.86 14 8.59 54 33.13 10 6.13 22 13.50 29 17.79 
High school 
(9-12) 
44 22.56 23 11.79 64 32.82 10 5.13 22 11.28 32 16.41 
Graduate 24 38.10 4 6.35 17 26.98 4 6.35 6 9.52 8 12.70 
Occupational  
status 




Housewife 20 27.03 4 5.41 27 36.49 1 1.35 4 5.41 18 24.32 
Daily labour 15 21.74 7 10.14 24 34.78 2 2.90 8 11.59 13 18.84 
Skilled 15 22.39 7 10.45 18 26.87 3 4.48 15 22.39 9 13.43 
Clerical 8 47.06 0 .00 3 17.65 0 .00 3 17.65 3 17.65 
Professional 5 62.50 0 .00 0 .00 0 .00 2 25.00 1 12.50 
Student 20 28.57 10 14.29 15 21.43 7 10.00 7 10.00 11 15.71 




























Duration of seizure 39.098
a
 .124 
Age of onset 70.373
a
 .002 
Seizure frequency 17.578 .063 



















indicates that more than 10% of cells have expected frequencies less than 5  
 
5.7.3. Association of structural abnormalities, EEG with neuroimaging findings 
 The side of the lesion in CT, MRI, DTI and EEG were associated with various 
structural lesions using chi-square test. The side of the lesion in MRI was significantly 
associated with MTS (right and left lesions) and bilateral nonspecific lesions. The side 
of the lesion in DTI was significantly associated with MTS (right, left and bilateral 
lesions). CT scan findings were associated with neoplastic- nonneoplastic lesion (right 
and left) and nonspecific lesions (right, left and bilateral) but the results were not 
considered significant due to 10% of cells has expected frequencies less than 5. The side 
of the lesion in EEG was associated with MTS (right and left), but the results were not 
considered significant due to 10% of cells has expected frequencies less than 5 as seen 







































Left 3 8.11 0 .00 4 10.81 1 2.70 16 43.24* 13 35.14* 
Bilateral 1 1.64 4 6.56 16 26.23 3 4.92 10 16.39 27 44.26* 




Normal 119 100.00 0 .00 0 .00 0 .00 0 .00 0 .00 
617.945 .000 
Right 0 .00 11 12.50 42 47.73* 5 5.68 17 19.32 13 14.77 
Left 0 .00 13 7.22 93 51.67* 30 16.67 26 14.44 18 10.00 




Normal 46 46.00 4 4.00 13 13.00 1 1.00 14 14.00 22 22.00 
63.508 .000 
Right 16 16.84 12 12.63 35 36.84* 8 8.42 14 14.74 10 10.53 
Left 29 18.35 13 8.23 66 41.77* 11 6.96 16 10.13 23 14.56 








Left 3 5.45 6 10.91 23 41.82* 3 5.45 12 21.82 8 14.55 
Bilateral 41 19.90 27 13.11 63 30.58* 18 8.74 23 11.17 34 16.50 




indicates that more than 10% of cells have expected frequencies less than 5  






























n Row % n Row % Value Sig. 
IQ Category 
Abnormal 31 12.35 37 14.74 89 35.46* 17 6.77 38 15.14 39 15.54 
44.104 .000 
Normal 88 34.51* 13 5.10 73 28.63 18 7.06 23 9.02 40 15.69 
MQ Category 
Abnormal 25 12.89 27 13.92 71 36.60* 13 6.70 28 14.43 30 15.46 
23.872 .000 
Normal 94 30.13* 23 7.37 91 29.17 22 7.05 33 10.58 49 15.71 
BGT 
Normal 91 31.60* 21 7.29 83 28.82 21 7.29 26 9.03 46 15.97 
30.499 .000 
Abnormal 28 12.84 29 13.30 79 36.24* 14 6.42 35 16.06 33 15.14 
Anxiety 
Absent 63 31.82* 15 7.58 56 28.28 14 7.07 20 10.10 30 15.15 
28.740 .001 Present 40 24.84 11 6.83 52 32.30* 10 6.21 24 14.91 24 14.91 
CNT 16 10.88 24 16.33 54 36.73 11 7.48 17 11.56 25 17.01 
Depression 
Absent 65 29.95* 18 8.29 65 29.95* 15 6.91 22 10.14 32 14.75 
27.711 .002 Present 38 26.76 8 5.63 43 30.28* 9 6.34 22 15.49 22 15.49 
CNT 16 10.88 24 16.33 54 36.73 11 7.48 17 11.56 25 17.01 
Anxiety and 
Depression 
Absent 68 29.18 19 8.15 72 30.90* 16 6.87 22 9.44 36 15.45 
29.838 .001 Present 35 27.78 7 5.56 36 28.57 8 6.35 22 17.46 18 14.29 
CNT 16 10.88 24 16.33 54 36.73 11 7.48 17 11.56 25 17.01 































n Row % n Row % Value Sig. 
IQ Category 
Abnormal 31 12.35 37 14.74 89 35.46* 17 6.77 38 15.14 39 15.54 
44.104 .000 
Normal 88 34.51* 13 5.10 73 28.63 18 7.06 23 9.02 40 15.69 
MQ 
Category 
Abnormal 25 12.89 27 13.92 71 36.60* 13 6.70 28 14.43 30 15.46 
23.872 .000 
Normal 94 30.13* 23 7.37 91 29.17 22 7.05 33 10.58 49 15.71 
BGT 
Normal 91 31.60* 21 7.29 83 28.82 21 7.29 26 9.03 46 15.97 
30.499 .000 
Abnormal 28 12.84 29 13.30 79 36.24* 14 6.42 35 16.06 33 15.14 
Anxiety 
Absent 63 31.82* 15 7.58 56 28.28 14 7.07 20 10.10 30 15.15 
28.740 .001 Present 40 24.84 11 6.83 52 32.30* 10 6.21 24 14.91 24 14.91 
CNT 16 10.88 24 16.33 54 36.73 11 7.48 17 11.56 25 17.01 
Depression 
Absent 65 29.95* 18 8.29 65 29.95* 15 6.91 22 10.14 32 14.75 
27.711 .002 Present 38 26.76 8 5.63 43 30.28* 9 6.34 22 15.49 22 15.49 




Absent 68 29.18 19 8.15 72 30.90* 16 6.87 22 9.44 36 15.45 
29.838 .001 Present 35 27.78 7 5.56 36 28.57 8 6.35 22 17.46 18 14.29 
CNT 16 10.88 24 16.33 54 36.73 11 7.48 17 11.56 25 17.01 






5.7.4. Neuropsychological manifestations of structural abnormalities in intractable  
epilepsy 
 Abnormal IQ scores (below average), MQ scores, BGT results were strongly 
associated (p<0.01) with MTS. A significant proportion of patients with intractable 
epilepsy who had no structural abnormalities had normal IQ scores, MQ scores, and 
BGT results.  A significant proportion of patients with MTS had anxiety and depression 
as seen in Table 18. Also, a significant proportion of patients without any structural 
abnormalities did not show any signs of anxiety or depression.  Another significant 
proportion of patients with MTS had combined symptoms of anxiety and depression 
(P<0.05) as seen in Table 18. 
 
Table 19:Association of Quality of life scores in various structural imaging findings 
 
*indicate level of significance p <0.05 
  
Total Quality of Life 
MRI 
Total 








Count 16 24 54 11 17 25 147 
Row % 10.88* 16.33* 36.73* 7.48 11.56* 17.01* 100.00 
Poor 
Count 12 2 18 3 7 8 50 
Row % 24.00* 4.00 36.00* 6.00 14.00* 16.00* 100.00 
Average 
Count 59 19 66 13 25 33 215 
Row % 27.44* 8.84 30.70* 6.05 11.63* 15.35* 100.00 
Good 
Count 32 5 24 8 12 13 94 
Row % 34.04* 5.32 25.53* 8.51 12.77* 13.83* 100.00 
Total 
Count 119 50 162 35 61 79 506 
Row % 23.52 9.88 32.02 6.92 12.06 15.61 100.00 




 Total quality of life was very poor in MCD, MTS, neoplastic and nonneoplastic, 
nonspecific lesions and patients without any structural abnormalities as seen in Table 19.  
36.73% of MTS patients followed by MCD (16.33%), non specific lesions (17.01%), 
neoplastic and nonneoplastic lesions (11.56%) had very poor quality of life. IHI patients 
did not show any association with the quality of life.  
 
5.8. Association of side of lesion across neuroimaging investigation  
 (CT, MRI, DTI) and EEG  
 
5.8.1. Association of side of lesion in CT vs MRI investigations  
 Out of 506 cases, 115 cases were found to be normal without any structural 
lesions in both CT and MRI. Out of 388 patients who had normal CT results, 273 
patients had abnormal results in MRI (right sided lesion (66), left sided lesion (139) and 
bilateral lesions (68)). Out 95 patients who had an abnormality in both CT and MRI, 18 
of them were found to have a lesion on the right, 29 of them were found to have a lesion 
on the left, and 48 of them were found to have a bilateral lesion.  Hence the consistency 
of CT and MRI results in the present the study is (115+18+29+48)/506 (*100) = 41.5%. 
If CT and MRI of patients with no structural abnormalities were ignored, then the 
consistency is (18 +29+48)/115 (*100) = 82.6% or nearly 83 %.  In other words, both 
CT and MRI imaging showed the same side of the lesion in more than 80% of patients 




Table 20: Association of Side of lesion in CT and MRI 
Side of lesion CT 
Side of lesion - MRI 
Total 
Normal Right Left Bilateral 
Right 
Count 0 18 1 1 20 
Row % .0 90.0* 5.0 5.0 100.0 
Left 
Count 3 3 29 2 37 
Row % 8.1 8.1 78.4* 5.4 100.0 
Bilateral 
Count 1 1 11 48 61 
Row % 1.6 1.6 18.0 78.7* 100.0 
Normal 
Count 115 66 139 68 388 
Row % 29.6* 17.0 35.8* 17.5 100.0 
Total 
Count 119 88 180 119 506 
Row % 23.5 17.4 35.6 23.5 100.0 
Pearson Chi-square Test: Value: 220.781;  Sig.: 0.000 
   Note: *level of significance P<0.05 
 
5.8.2. Association of side of lesion on MRI and DTWI 
 From the present study, we observed a significant proportion of patients who 
have normal MRI showed significant DTI abnormalities (left and bilateral hemispheres 
of the brain). A significant proportion of patient with right hemisphere MRI lesions 
showed right and bilateral hemispheric abnormalities in DTWI as seen in Table 21.  
Similarly, a significant proportion of patients with left hemispheric lesions in MRI 
showed left or bilateral hemispheric lesions. Also, a significant proportion of patients 
who showed bilateral lesions in MRI showed bilateral abnormalities in DTWI. The 
consistency of MRI and DTI results in the present study is [(54 + 103 +68)/ (79 
+129+125)] * 100 = 67.57%  
Table 21:Association of side of lesion in MRI with DTWI 
Side of lesion - MRI 
Side of lesion – DTWI 
Total 
Normal Right Left Bilateral 
Normal 
Count 46 16 29 28 119 
Row % 38.7* 13.4 24.4* 23.5* 100.0 
Right 
Count 11 54 5 18 88 
Row % 12.5 61.4* 5.7 20.5* 100.0 
Left 
Count 24 14 103 39 180 
Row % 13.3 7.8 57.2* 21.7* 100.0 
Bilateral 
Count 19 11 21 68 119 
Row % 16.0 9.2 17.6 57.1* 100.0 
Total 
Count 100 95 158 153 506 
Row % 19.8 18.8 31.2 30.2 100.0 
Pearson’s Chi-Square Test: Value: 236.226; Sig.: 0.000 
Note: *level of significance P<0.05  
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5.8.3. Association of side of lesion in MRI and side of abnormality in EEG 
 A significant proportion of patients without structural lesion in MRI (61.3%), 
right (43.2%) or left (37.8%) or bilateral (34.5%) abnormalities in MRI did not reveal 
any abnormalities in EEG. Also, one-third of patients (34.5%) without structural 
abnormalities in MRI did show bilateral epileptiform discharges from both hemispheres. 
Patients with right-sided abnormalities in MRI showed significant EEG abnormalities in 
the right hemisphere (25%) and bilateral hemispheres (28.4%). Similarly, patients with 
left hemispheric lesions in MRI showed a significant amount of EEG abnormalities in 
left (25%) and bilateral hemispheres (36.7%). Bilateral lesion often showed significant 
bilateral EEG abnormalities in 62.2% of the population as seen in Table 22. The 
consistency of MRI and EEG results in the present study is [(22+45+74)/ (23+52+165)] 
* 100 = 58.75%. 
 
Table 22: Association of side of lesion in MRI and EEG 
 
Side of lesion - MRI 
Side of lesion – EEG 
Total 
Right Left Bilateral Non-significant 
Normal 
Count 2 3 41 73 119 
Row % 1.7 2.5 34.5* 61.3* 100.0 
Right 
Count 22 3 25 38 88 
Row % 25.0* 3.4 28.4* 43.2* 100.0 
Left 
Count 1 45 66 68 180 
Row % .6 25.0* 36.7* 37.8* 100.0 
Bilateral 
Count 0 4 74 41 119 
Row % .0 3.4 62.2* 34.5* 100.0 
Total 
Count 25 55 206 220 506 
Row % 4.9 10.9 40.7 43.5 100.0 
Pearson’s Chi-Square Test:  Value: 169.417; Sig.: 0.00 
Note: *level of significance P<0.05 
 
5.8.4. Association of side of lesion between DTI and EEG 
 Patients who had normal DTWI finding, 24% showed significant bilateral EEG 
abnormalities and 64% of them did not show any EEG abnormalities. A significant 
proportion of patients who had right or left or bilateral hemispheric abnormalities in 
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DTWI significantly showed bilateral EEG abnormalities as seen in Table 23. The 
consistency of DTWI and EEG results in the present study is [(19+34+95)/ 
(22+46+182)] * 100 = 59.2%. 
 
Table 23:Association of side of lesion in DTWI and EEG 
Side of lesion - DTWI 
Side of lesion – EEG 
Total 
Right Left Bilateral Non-significant 
Normal 
Count 3 9 24 64 100 
Row % 3.0 9.0 24.0* 64.0* 100.0 
Right 
Count 19 5 25 46 95 
Row % 20.0 5.3 26.3* 48.4* 100.0 
Left 
Count 0 34 62 62 158 
Row % .0 21.5 39.2* 39.2* 100.0 
Bilateral 
Count 3 7 95 48 153 
Row % 2.0 4.6 62.1* 31.4* 100.0 
Total 
Count 25 55 206 220 506 
Row % 4.9 10.9 40.7 43.5 100.0 
Pearson’s Chi-Square Test: Value: 125.043;     Sig.: 0.000 
Note: *level of significance P<0.05 
 
5.9. Role of Neuroimaging results (CT, MRI, and DTI) and EEG in identifying  
 structural lesions 
 CT scan results have a greater chance in identifying non-specific lesions (40.7%) 
and neoplastic-nonneoplastic lesions (29.7%). Altogether CT scan has 70% chance to 
identify neoplastic - nonneoplastic lesions or non-specific lesions. MRI results have a 
higher chance (41.9%) identifying MTS. Similar to MRI, DTI also has a greater chance 
of detecting an abnormality in MTS (36.7%). EEG revealed abnormal results in MTS 
which is a form of focal lesion associated with CPS. Among MCD, MRI had higher 
sensitivity when compared to CT scan. 
 
None of the imaging techniques used could identify any abnormalities in 6.13% 
(n=31) of patients with intractable epilepsy. Interestingly, DTI could identify an 
abnormality in 7.91% (n=40) of patients with intractable epilepsy apart from all other 
investigations. If MRI and DTI were combined for investigating intractable epilepsy 
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patients, the frequency of identifying structural abnormalities increased to 18.58% (n= 
94). If MRI, DTI and interictal EEG were combined, it could identify abnormalities in 
30.24% (n=153). If all the four investigations showed consistent abnormality in 12.85% 
(n=65). Comparison of results among various techniques is shown in Table 24 and 25. 
 
Table 24:Comparison of structural lesions identified through various neuroimaging 




CT Result MRI result DTWI Result EEG Result 
Normal Abnormal Normal Abnormal Normal Abnormal Normal Abnormal 
n % n % n % n % n % n % n % n % 
Normal 115 29.6 4 3.4 119 100.0 0 .0 46 46.0 73 18.0* 73 33.2 46 16.1* 
MCD 46 11.9 4 3.4 0 .0 50 12.9* 4 4.0 46 11.3* 16 7.3 34 11.9* 
MTS 142 36.6 20 16.9* 0 .0 162 41.9* 13 13.0 149 36.7* 62 28.2 100 35.0* 





26 6.7 35 29.7* 0 .0 61 15.8* 14 14.0 47 11.6* 20 9.1 41 14.3* 
Nonspecific 
lesion 
31 8.0 48 40.7* 0 .0 79 20.4* 22 22.0 57 14.0* 35 15.9 44 15.4* 




Table 25: Comparison of various imaging abnormalities in identifying structural 
abnormalities of brain  
Imaging techniques n % 
All normal 31 6.13 
CT alone abnormal 1 .20 
MRI alone abnormal 14 2.77 
DTWI alone abnormal 40 7.91 
EEG alone abnormal 13 2.57 
CT & MRI abnormal 18 3.56 
CT & DTWI abnormal 1 .20 
CT & EEG abnormal 1 .20 
MRI & DTWI abnormal 94 18.58 
MRI & EEG abnormal 12 2.37 
DTWI & EEG abnormal 31 6.13 
CT, MRI & EEG abnormal 10 1.98 
CT, MRI & DTWI abnormal 21 4.15 
CT, DTWI & EEG abnormal 1 .20 
MRI, DTWI & EEG abnormal 153 30.24 
All abnormal 65 12.85 
 
5.10. Association between education and occupation in intractable epilepsy 
 Chi-square test was applied to associate education and occupational levels in 
intractable epilepsy. Occupational status was grouped into 1) unemployed (unemployed 
+ housewife), 2) Employed (daily labourer, skilled, clerical, professional) and 3) 
Students for analysis. Intractable epilepsy being a heterogeneous group (cognitive 
functions, structural abnormalities) showed the varied level of educational status and 
occupation. Patients without any school education (63.53%), elementary level of 
education (65.64%) and high school level of education (46.67%) were significantly 
associated with unemployment as seen in Table 26. Also, 31.28% of the population with 
high school education and 42.86% of the population with a graduate level of education 
were significantly associated with employment.   
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Unemployed Employed Student 
No school education 
Count 54 30 1 85 
Row % 63.53* 35.29 1.18 100.00 
Col % 19.64 18.63 1.43 16.80 
Elementary (1-8) 
Count 107 43 13 163 
Row % 65.64* 26.38 7.98 100.00 
Col % 38.91 26.71 18.57 32.21 
High school (9-12) 
Count 91 61 43 195 
Row % 46.67* 31.28* 22.05 100.00 
Col % 33.09 37.89 61.43 38.54 
Graduate 
Count 23 27 13 63 
Row % 36.51 42.86* 20.63 100.00 
Col % 8.36 16.77 18.57 12.45 
Total 
Count 275 161 70 506 
Row % 54.35 31.82 13.83 100.00 
Col % 100.00 100.00 100.00 100.00 
Pearson Chi-Square Value: 40.732; Sig.: 0.000 
 
5.10.1. Factors contributing to education in patients with intractable epilepsy 
 Chi-square test was applied to find out the association of demographic variables, 
structural abnormalities and psychological variables that contribute to education and 
unemployment in patients with intractable epilepsy. A significant proportion of patients 
(41.18%) who had a younger age of onset of seizure had no school education followed 
by 29.45% of them have an elementary level of education. Also, longer duration 
seizures (16-20 years) had a significant proportion of association with no schooling 
(30.59%) and elementary level of education (20.25%). An equal proportion of patients 
with longer duration of seizure had significant association across all the education level. 
91.76% of them who were under polytherapy had no schooling, and 88.96% of them 
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who were under polytherapy had education up to the elementary level as seen in  
Table 28. No significant association of employment was observed with a medical history 
as seen in Table 27.  
 
















(n = 195) 
Graduate 
(n =63) 
n % n % n % n % Value Sig. 
Developmental 
milestones 
Normal 69 81.18 144 88.34 171 87.69 49 77.78 
6.155 .104 
Delayed 16 18.82 19 11.66 24 12.31 14 22.22 
Natal history 
Not significant 75 88.24 151 92.64 187 95.90 61 96.83 
9.387 .153 LSCS 2 2.35 5 3.07 3 1.54 1 1.59 
Asphyxia 8 9.41 7 4.29 5 2.56 1 1.59 
Post natal history 
Not significant 80 94.12 152 93.25 188 96.41 58 92.06 
16.984 .320 
Infections 0 .00 5 3.07 0 .00 1 1.59 
Head injury 1 1.18 1 .61 2 1.03 1 1.59 
Stroke 2 2.35 1 .61 0 .00 0 .00 
Febrile seizures 2 2.35 3 1.84 3 1.54 2 3.17 
Hypothyroidism 0 .00 1 .61 2 1.03 1 1.59 
Family history 
Absent 76 89.41 151 92.64 185 94.87 60 95.24 
3.310 .346 





Table 28:Association of clinical characteristics of intractable epilepsy with education 











(n = 163) 
High school 
(9-12) 
(n = 195) 
Graduate 
(n =63) 
n % n % n % n % Value Sig. 
Duration of 
seizure 
0-5 8 9.41 17 10.43 25 12.82 14 22.22* 
35.593 .008 
6-10 9 10.59* 31 19.02* 52 26.67* 21 33.33* 
11-15 22 25.88* 41 25.15* 33 16.92* 8 12.70* 
16-20 26 30.59* 33 20.25* 40 20.51* 10 15.87* 
21-25 4 4.71 13 7.98 15 7.69 6 9.52 
26-30 6 7.06 13 7.98 18 9.23 2 3.17 
30+ 10 11.76 15 9.20 12 6.15 2 3.17 
Age of onset 
0-5 35 41.18* 48 29.45* 59 30.26* 11 17.46* 
40.164 .021 
6-10 9 10.59* 38 23.31* 39 20.00* 12 19.05* 
11-15 13 15.29* 29 17.79* 27 13.85* 8 12.70* 
16-20 5 5.88 16 9.82 28 14.36* 8 12.70* 
21-25 8 9.41 10 6.13 13 6.67 4 6.35 
26-30 6 7.06 7 4.29 15 7.69 9 14.29* 
31-35 3 3.53 6 3.68 6 3.08 7 11.11* 
36-40 1 1.18 3 1.84 6 3.08 3 4.76 
> 40 Years 5 5.88 6 3.68 2 1.03 1 1.59 
Seizure 
frequency 
Daily 15 17.65 24 14.72 34 17.44 7 11.11 
3.245 .778 1-6 Weekly 24 28.24 54 33.13 56 28.72 17 26.98 
1-4 Month 46 54.12 85 52.15 105 53.85 39 61.90 
Clustering of 
present seizure 
0 45 52.94 99 60.74 111 56.92 41 65.08 
8.465 .488 
1-2 27 31.76 38 23.31 63 32.31 17 26.98 
2-3 10 11.76 18 11.04 13 6.67 3 4.76 
>3 3 3.53 8 4.91 8 4.10 2 3.17 
Precipitating 
factor 






14 16.47 21 12.88 31 15.90 12 19.05 
Febrile illness 3 3.53 5 3.07 2 1.03 0 .00 
Nocturnal 4 4.71 6 3.68 4 2.05 2 3.17 
Others 2 2.35 9 5.52 6 3.08 4 6.35 
Status epilepsy 
Absent 77 90.59 150 92.02 180 92.31 57 90.48 
.379 .945 
Present 8 9.41 13 7.98 15 7.69 6 9.52 
Neuro 
examination 
Not significant 63 74.12 118 72.39 150 76.92 47 74.60 
10.497 .312 
Headache 14 16.47 33 20.25 40 20.51 14 22.22 
Hemiparesis 6 7.06 7 4.29 2 1.03 2 3.17 
Neurocutaneous 
markers 
2 2.35 5 3.07 3 1.54 0 .00 
Comorbid 
conditions 
Not significant 77 90.59 131 80.37 158 81.03 54 85.71 
14.517 .487 
Migraine 7 8.24 26 15.95 32 16.41 6 9.52 
Headtrauma 1 1.18 6 3.68 2 1.03 3 4.76 
Alcohol 0 .00 0 .00 1 .51 0 .00 
Smoking 0 .00 0 .00 1 .51 0 .00 
Substanceabuse 0 .00 0 .00 1 .51 0 .00 
Drug 
Monotherapy 7 8.24 18 11.04 37 18.97 15 23.81* 
11.152 .011 
Polytherapy 78 91.76* 145 88.96* 158 81.03* 48 76.19* 
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 The various structural lesions, side of lesion across various neuroimaging 
techniques and EEG did not associate significantly with any category of education being 
considered for the study as seen in Table 29. 48.24% and 12.94% of the population who 
had low IQ scores had no school education.  High IQ scores were associated with the 
graduate level of education in 73.02% of the population. 85.71% and 65.64% of them 
who had normal MQ scores fall undergraduate and high school education category. 
55.29% and 43.56% of patients who had low MQ scores have not undergone any school 
education and studied the only elementary level of education respectively. 71.43% of the 
population with normal BGT results significantly correlated with the graduate level of 
education. 58.82% and 48.47% of the population who had abnormal BGT scores were 
uneducated and had an only elementary level of education.An equal proportion of 
patients with anxiety, depression, and mixed anxiety depression symptoms fall in 




Table 29:Association of radio-imaging techniques and EEG with education 
 






(n = 85) 
Elementary (1-8) 
(n = 163) 
High school 
(9-12) 
(n = 195) 
Graduate 
(n =63) 
n % n % n % n % Value Sig. 
CT Scan 




Calcification 9 10.59 20 12.27 19 9.74 5 7.94 
Infarction 4 4.71 5 3.07 0 .00 1 1.59 
Gliosis 3 3.53 11 6.75 5 2.56 2 3.17 
Atrophy 9 10.59 7 4.29 6 3.08 5 7.94 
Lissenchephaly 1 1.18 0 .00 0 .00 0 .00 
Neoplastic 0 .00 1 .61 1 .51 0 .00 
Non-neoplastic 0 .00 1 .61 3 1.54 0 .00 
Side of lesion 
CT 




Left 10 11.76 10 6.13 12 6.15 5 7.94 
Bilateral 14 16.47 25 15.34 17 8.72 5 7.94 
Normal 59 69.41 118 72.39 161 82.56 50 79.37 
CT Result 
Abnormal 26 30.59 45 27.61 34 17.44 13 20.63 
8.216 .042 
Normal 59 69.41 118 72.39 161 82.56 50 79.37 
Structural 
lesions (MRI) 
Normal 17 20.00 34 20.86 44 22.56 24 38.10 
17.171 .309 
MCD 9 10.59 14 8.59 23 11.79 4 6.35 
MTS 27 31.76 54 33.13 64 32.82 17 26.98 
IHI 11 12.94 10 6.13 10 5.13 4 6.35 
Neoplastic lesions 11 12.94 22 13.50 22 11.28 6 9.52 
Nonspecific lesion 10 11.76 29 17.79 32 16.41 8 12.70 
MRI - 
Classification 
Abnormal 68 80.00 129 79.14 151 77.44 39 61.90 
8.767 .033 
Normal 17 20.00 34 20.86 44 22.56 24 38.10 
Side of lesion - 
MRI 
Normal 17 20.00 34 20.86 44 22.56 24 38.10 
19.473 .021 
Right 9 10.59 32 19.63 37 18.97 10 15.87 
Left 42 49.41 51 31.29 71 36.41 16 25.40 
Bilateral 17 20.00 46 28.22 43 22.05 13 20.63 
MRI result 
Abnormal 68 80.00 129 79.14 151 77.44 39 61.90 
8.767 .033 
Normal 17 20.00 34 20.86 44 22.56 24 38.10 
Side of lesion - 
DTWI 
Normal 18 21.18 32 19.63 34 17.44 16 25.40 
12.308 .197 
Right 9 10.59 40 24.54 38 19.49 8 12.70 
Left 29 34.12 49 30.06 64 32.82 16 25.40 
Bilateral 29 34.12 42 25.77 59 30.26 23 36.51 
DTWI Result 
Abnormal 67 78.82 131 80.37 161 82.56 47 74.60 
2.036 .565 
Normal 18 21.18 32 19.63 34 17.44 16 25.40 
EEG 
Normal 28 32.94 65 39.88 97 49.74 30 47.62 
12.272 .056 Focal 13 15.29 34 20.86 26 13.33 7 11.11 
Generalised 44 51.76 64 39.26 72 36.92 26 41.27 
Side of lesion - 
EEG 




Left 12 14.12 23 14.11 15 7.69 5 7.94 
Bilateral 44 51.76 64 39.26 72 36.92 26 41.27 
Non-significant 28 32.94 65 39.88 97 49.74 30 47.62 
EEG Result 
Abnormal 57 67.06 98 60.12 98 50.26 33 52.38 
8.255 .041 
Normal 28 32.94 65 39.88 97 49.74 30 47.62 
Semiology 
change 
No change 30 35.29 58 35.58 64 32.82 25 39.68 
1.042 .791 















(n = 85) 
Elementary 
(1-8) 
(n = 163) 
High school 
(9-12) 
(n = 195) 
Graduate 
(n =63) 
n % n % n % n % Value Sig/ 
IQ 
≤ 69 : Mental 
retardation 
41 48.24* 47 28.83* 50 25.64* 9 14.29 
32.539 .000 70 - 90: Dull 
normal 
11 12.94 42 25.77 43 22.05 8 12.70 
> 90: Average 
intelligence 
33 38.82* 74 45.40* 102 52.31 46 73.02* 
MQ 
≥ 70:  Normal 38 44.71* 92 56.44* 128 65.64 54 85.71* 
28.939 .000 
< 70:  Deficits of 
memory 
dysfunction 
47 55.29* 71 43.56* 67 34.36 9 14.29 
BGT 
Normal 35 41.18 84 51.53* 124 63.59* 45 71.43* 
19.466 .000 
Abnormal 50 58.82* 79 48.47* 71 36.41* 18 28.57 
Anxiety 
Absent 30 35.29 65 39.88* 73 37.44* 30 47.62* 
26.609 .000 
Present 14 16.47 51 31.29* 72 36.92* 24 38.10* 
CNT 41 48.24* 47 28.83 50 25.64 9 14.29 
Depression 
Absent 29 34.12* 74 45.40* 84 43.08* 30 47.62* 
24.945 .000 
Present 15 17.65 42 25.77 61 31.28* 24 38.10* 




Absent 31 36.47* 81 49.69* 88 45.13* 33 52.38* 
26.214 .000 
Present 13 15.29 35 21.47 57 29.23* 21 33.33* 
CNT 41 48.24* 47 28.83* 50 25.64 9 14.29 









Square Test Unemployed 




(n = 70) 
n % n % n % Value Sig. 
Developmental 
milestones 
Normal 231 84.00 147 91.30 55 78.57 
7.615 .062 
Delayed 44 16.00 14 8.70 15 21.43 
Natal history 
Not significant 251 91.27 157 97.52 66 94.29 
7.077
a
 .132 LSCS 9 3.27 1 .62 1 1.43 
Asphyxia 15 5.45 3 1.86 3 4.29 
Post natal 
history 




Infections 2 .73 4 2.48 0 .00 
Head injury 3 1.09 1 .62 1 1.43 
Stroke 3 1.09 0 .00 0 .00 
Febrile seizures 7 2.55 1 .62 2 2.86 
Hypothyroidism 1 .36 2 1.24 1 1.43 




5.10.2. Factors contributing to occupation in patients with intractable epilepsy 
 Among clinical characteristics duration of seizure (longer than 16-20 years) was 
significantly associated with unemployment. Patients who had a younger age of onset 
(6-10 years) had a significant association with employment. Almost equal proportion of 
patients with intractable epilepsy for whom did not have an episode of status epilepsy 
were unemployed, employed and student which indication no association of status 
epilepsy with unemployment. Drugs (polytherapy) were significantly associated with 
unemployment, employment, and students in equal proportion. None of the other 
clinical characteristics significantly associated with employment status (p>0.05) as seen 
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in Table 32. Medical history was not associated with occupation in the present 
population as seen in Table 31.  
 
 Among structural imaging techniques, none of them had an association with 
employment as seen in Table 33. Structural abnormalities like MTS had a significant 
association with unemployment (37.09%). Also, patients who did not show any 
structural abnormalities had 20.36% chance of unemployment. The side of lesion and 
EEG finding did not associate with employment. A Higher proportion of patients with 
mental retardation (40%) and low MQ scores (48.36%) were significantly associated 
with unemployment. Patients with normal IQ scores (65.22%) and MQ scores (75.16%) 
were significantly associated with employment (65.22%). Normal BGT scores were 
significantly associated with employment (62.73%). The absence of anxiety (46.58%), 
depression (55.28%) and anxiety- depression (57.76%) was significantly associated with 





Table 32: Association of clinical characteristics with employment 
 
Clinical Characteristics 
Occupation Pearson Chi-Square Test 
Unemployed 




(n = 70) 
 
n % n % n % Value Sig. 
Neurocutaneous 
markers 




Present 3 1.09 5 3.11 2 2.86 
Duration of 
seizure 
0-5 29 10.55 22 13.66 13 18.57 
43.568 .000 
6-10 51 18.55 41 25.47* 21 30.00* 
11-15 53 19.27 25 15.53 26 37.14* 
16-20 71 25.82* 29 18.01 9 12.86 
21-25 23 8.36 14 8.70 1 1.43 
26-30 21 7.64 18 11.18 0 .00 
30+ 27 9.82 12 7.45 0 .00 
Age of onset 




6-10 64 23.27 13 8.07 21 30.00 
11-15 39 14.18 30 18.63 8 11.43 
16-20 29 10.55 25 15.53 3 4.29 
21-25 19 6.91 16 9.94 0 .00 
26-30 14 5.09 22 13.66 1 1.43 
31-35 11 4.00 11 6.83 0 .00 
36-40 5 1.82 8 4.97 0 .00 
> 40 Years 4 1.45 10 6.21 0 .00 
Seizure frequency 
Daily 48 17.45 16 9.94 16 22.86 
13.680
a
 .008 1-6 Weekly 91 33.09 40 24.84 20 28.57 
1-4 Month 136 49.45 105 65.22 34 48.57 
Clustering of 
present seizure 
0 160 58.18 96 59.63 40 57.14 
4.131 .659 
1-2 79 28.73 49 30.43 17 24.29 
2-3 23 8.36 12 7.45 9 12.86 
>3 13 4.73 4 2.48 4 5.71 
Precipitating 
factor 
Not significant 209 76.00 119 73.91 53 75.71 
6.183 .627 
Sleeep deprivation 41 14.91 28 17.39 9 12.86 
Febrile illness 7 2.55 2 1.24 1 1.43 
Nocturnal 5 1.82 7 4.35 4 5.71 
Others 13 4.73 5 3.11 3 4.29 
Status epilepsy 
Absent 251 91.27* 154 95.65* 59 84.29* 
8.425 .015 
Present 24 8.73 7 4.35 11 15.71 
Neuro 
examination 
Not significant 200 72.73 122 75.78 56 80.00 
6.277 .393 
Headache 62 22.55 30 18.63 9 12.86 
Hemiparesis 10 3.64 4 2.48 3 4.29 
Neurocutaneous 
markers 
3 1.09 5 3.11 2 2.86 
Comorbid 
conditions 
Not significant 224 81.45 136 84.47 60 85.71 
12.845 .232 
Migraine 44 16.00 20 12.42 7 10.00 
Headtrauma 7 2.55 3 1.86 2 2.86 
Alcohol 0 .00 1 .62 0 .00 
Smoking 0 .00 1 .62 0 .00 
Substanceabuse 0 .00 0 .00 1 1.43 
Drug 
Monotherapy 31 11.27 32 19.88 14 20.00 
7.266 .026 
Polytherapy 244 88.73* 129 80.12* 56 80.00* 
Note: * indicate level of significance <0.05 
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Table 33: Association of radio-imaging techniques and EEG with employment 
 
Structural and EEG findings 
Occupation Pearson Chi-Square Test 
Unemployed 




(n = 70) 
 
n % n % n % Value Sig. 
CT Scan 




Calcification 28 10.18 19 11.80 6 8.57 
Infarction 4 1.45 6 3.73 0 .00 
Gliosis 10 3.64 7 4.35 4 5.71 
Atrophy 18 6.55 7 4.35 2 2.86 
Lissenchephaly 1 .36 0 .00 0 .00 
Neoplastic 1 .36 1 .62 0 .00 
Non-neoplastic 0 .00 4 2.48 0 .00 
Side of lesion 
CT 
Right 9 3.27 7 4.35 4 5.71 
6.910 .329 
Left 18 6.55 17 10.56 2 2.86 
Bilateral 35 12.73 20 12.42 6 8.57 
Normal 213 77.45 117 72.67 58 82.86 
CT Result 
Abnormal 62 22.55 44 27.33 12 17.14 
3.033 .219 
Normal 213 77.45 117 72.67 58 82.86 
Structural 
lesions (MRI) 
Normal 56 20.36* 43 26.71* 20 28.57* 
20.585 .024 
MCD 26 9.45 14 8.70 10 14.29 
MTS 102 37.09* 45 27.95* 15 21.43* 
IHI 23 8.36 5 3.11 7 10.00 
Neoplastic and Non 
neoplastic lesions 
26 9.45 28 17.39 7 10.00 
Nonspecific lesion 42 15.27 26 16.15 11 15.71* 
MRI - 
Classification 
Abnormal 219 79.64 118 73.29 50 71.43 
3.426 .180 
Normal 56 20.36 43 26.71 20 28.57 
Side of lesion - 
MRI 
Normal 56 20.36 43 26.71 20 28.57 
7.122 .310 
Right 48 17.45 26 16.15 14 20.00 
Left 101 36.73 61 37.89 18 25.71 
Bilateral 70 25.45 31 19.25 18 25.71 
MRI result 
Abnormal 219 79.64 118 73.29 50 71.43 
3.426 .180 
Normal 56 20.36 43 26.71 20 28.57 
Side of lesion - 
DTWI 
Normal 46 16.73 42 26.09 12 17.14 
8.381 .211 
Right 56 20.36 23 14.29 16 22.86 
Left 86 31.27 52 32.30 20 28.57 
Bilateral 87 31.64 44 27.33 22 31.43 
DTWI Result 
Abnormal 229 83.27 119 73.91 58 82.86 
5.962 .051 
Normal 46 16.73 42 26.09 12 17.14 
EEG 
Normal 112 40.73 79 49.07 29 41.43 
3.355 .500 Focal 44 16.00 25 15.53 11 15.71 
Generalised 119 43.27 57 35.40 30 42.86 
Side of lesion - 
EEG 
Right 14 5.09 8 4.97 3 4.29 
3.448 .751 
Left 30 10.91 17 10.56 8 11.43 
Bilateral 119 43.27 57 35.40 30 42.86 
Non-significant 112 40.73 79 49.07 29 41.43 
EEG Result 
Abnormal 163 59.27 82 50.93 41 58.57 
3.014 .222 
Normal 112 40.73 79 49.07 29 41.43 
Semiology 
change 
No change 88 32.00 63 39.13 26 37.14 
2.437 .296 
Change 187 68.00 98 60.87 44 62.86 









Square Test Unemployed 




(n = 70) 
n % n % n % Value Sig. 
IQ 
≤ 69 : Mentalretardation 110 40.00* 21 13.04 16 22.86 
46.653 .000 
70 - 90: Dull normal slow 
learners 
60 21.82 35 21.74 9 12.86 
> 90: Average intelligene 105 38.18* 105 65.22* 45 64.29* 
MQ 
≥ 70:  Normal 142 51.64* 121 75.16* 49 70.00* 
  
< 70:  Deficits of memory 
dysfunction 
133 48.36* 40 24.84 21 30.00 
BGT 
Normal 132 48.00* 101 62.73* 55 78.57* 
24.524 .000 
Abnormal 143 52.00* 60 37.27 15 21.43 
Anxiety 
Absent 89 32.36 75 46.58* 34 48.57* 
39.017 .000 Present 76 27.64 65 40.37* 20 28.57* 
CNT 110 40.00 21 13.04 16 22.86 
Depression 
Absent 92 33.45* 89 55.28* 36 51.43* 
40.247 .000 Present 73 26.55 51 31.68 18 25.71 
CNT 110 40.00* 21 13.04 16 22.86 
Anxiety and 
Depression 
Absent 102 37.09 93 57.76* 38 54.29* 
38.842 .000 Present 63 22.91 47 29.19 16 22.86 
CNT 110 40.00* 21 13.04 16 22.86 



















6.1. Demographics of intractable epilepsy 
6.1.1. Prevalence of intractable epilepsy  
The prevalence of intractable epilepsy (21.05%) of the present study was 
comparable to the western studies 
8,138
, that considered Drug-resistant Epilepsy (ILAE, 
2010) criteria. The prevalence rates of adults with intractable epilepsy were similar to 
those studies done with drug-resistant epilepsy criteria.  Despite differences in the 
definition, the prevalence of intractable epilepsy in this study was congruent to that of 
the western studies 
5,7,138
 in which the prevalence ranged from 15.6% to 22.5%. Higher 
frequency of patients with intractable epilepsy was observed in the age range of 16-20 
years followed 26-30 years age range, which was similar to the results of a study that 
showed increased prevalence in 20-29 yrs 
108
, a hospital-based study in Singapore. The 
present results were not in congruence with results of a population-based study in North 
Italy 
138
 which showed increased prevalence in the age range of 35 - 54 years.   
Decreased prevalence was observed in the age range >60 years (1.38%) were similar to 
both the studies 
108,138
 that showed the reduced prevalence of intractable epilepsy (> 55 
years of age). There are no studies in India regarding the prevalence of intractable 
epilepsy especially using drug-resistant epilepsy (ILAE, 2010) criteria. 
 
6.1.2. Gender differences 
In the present study, the prevalence of intractable epilepsy was majorly observed 
in males compared to females 
3, 4, 78, 106
 which is comparable to several studies done in 
India except for a study which indicates a high prevalence in females rather than males. 
This could be possible due to the patient attending the epilepsy clinics were majorly 
males compared to females. There may be influences of low socioeconomic status, 
educational and cultural factors over the patients who avail treatment in developing 
countries that cause treatment gap among females 
10,139–141
. Also, the low prevalence in 
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women receiving treatment for epilepsy in the present study is supported by a study done 




6.1.3. Educational status 
The present study revealed 16.8% of illiteracy in adults with intractable 
epilepsy. Currently, there is no literature regarding the educational status of adults 
with intractable epilepsy. The preliminary studies carried out in children with epilepsy 
show a high prevalence of educational problems (36%) 
143
. They attributed the low 
academic performance to psychiatric illness like attention deficit hyperkinetic disorder, 
conduct disorder and depression (47%) followed by decreased learning opportunities 
(22.2%) and borderline intelligence (19.4%). Another hospital-based report showed poor 
academic performance in 26.1% of urban patients and 38.3% of rural patients with 
epilepsy 
144
.  In the study population, a majority of intractable epilepsy patients have 
discontinued education at the elementary level (32.21%, n=163) and at high school level 
(38.54%, n=195) which could be due to the chronicity of the disease, low cognition, 
memory deficits, low socioeconomic status, anxiety and depression.  
 
6.1.4. Occupational status 
Though a significant group of the population has completed high school 
(38.54%) and graduation (12.45%) a high proportion of patients with intractable epilepsy 
(36.96%) were unemployed. A Study of 872 patients with epilepsy at an outpatient clinic 
at Spain showed employment rates of 58%, 10.9% unemployed and 12.5% 
occupationally incapacitated 
145
. They concluded that the employment rates were similar 
to those of the general population and slightly higher levels of unemployment. They 
unemployment in their population were significantly associated with refractory epilepsy, 
the low level of education and polytherapy. We compared unemployment rates in the 
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present study with the unemployment rates in India.  In India from1983 to 2011, 
unemployment rates were reported to be range from 3.8 to 9.4% 
146
. The unemployment 
in patients with intractable epilepsy (36.96%) is significantly higher than the 
unemployment in general population and patients with epilepsy.  
 
6.2. Clinical characteristics of  adults with intractable epilepsy 
6.2.1. Type of seizure 
 The type of seizure mostly observed in the present study population is of partial 
type, especially complex partial seizures. The order of seizure type in the present study 
are comparable to the reports by Tripathi et al.
11
 in North India where they reported 
majorly partial seizures (83%) followed by generalised seizures (7%), myoclonic (6.5%) 
and mixed epilepsy (3.5%). There are differences between the frequencies of seizure type 
among the studies can due to the differences in subjects selection criteria considered for 
intractable epilepsy 
147
. We have followed the ILAE (2010) criteria for the subject 
selection. The type of seizure and clinical characteristics of intractable epilepsy in India 
is comparable to the studies done in Singapore 
8
 and Italy 
7
. From the present study, we 
observed commonly partial seizures (72.92%) followed by generalised seizures (27.08%) 
that are comparable to both studies that have similar findings. 
 
6.2.2. Duration and onset of seizure 
Most of the patients in the present study showed a longer duration of seizure 
intractability that ranges from 6 years to 20 years. Almost 30% of them had a younger 
age of onset of seizures (less than 5 years of the age) which reported being a predictor for 
intractable epilepsy among a large sample of epilepsy patients 
133
. Most of the patients in 
the intractable epilepsy group were mesial temporal sclerosis (32.02%, n=162) and 
incomplete hippocampal inversion. MTS being a hippocampal lesion that occurs after an 
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initial precipitating injury during birth or 0-5 years of age, may cause damage to the cells 
(CA1, CA4) in the hippocampus and may remain silent. After sprouting of dentate gyrus 
granule cell layer and its axons (mossy fibers) into molecular layer, there is an excitation 
and inhibition mismatch leading to increased excitation resulting in recurrence of seizure 
with a change in semiology 
64
. From the present study, it was observed that high 
proportion of patients with intractable epilepsy from the age range of 6-20 years who had 
an early onset of seizure which were due to various conditions like febrile illness, 
infection and birth trauma, also these patients had a silent period before developing 
intractability. 
 
6.2.3. Seizure frequency 
From the present study, it was observed that seizure frequency were 1-4 episodes 
per month (54.35%, n=275), followed by 1-6 episodes per week (29.84%,n=151) and 
daily occurrence (15.81%, n=80) which signifies severity of damage to the brain 
parenchyma. Patients having a seizure more than one per day was associated with 
structural lesions like MCD 
52
. 54.35% of intractable epilepsy patients had seizure 
frequency of 1-4 episode of seizure per month in this large cohort. These findings were 
supported by a study done using DRE criteria in Singapore who report pretreatment 
seizure frequency of more than once monthly to be a predictor of drug-resistant epilepsy 
108
. Also in India higher frequency of initial seizure of more than one per month is 




6.2.4. Seizure semiology changes 
Also from the records and neurological investigations, it was observed that 
65.02% had changed in seizure semiology. The majority of the patients have one or 
several identifiable structural abnormalities in 93.9% of the population using several 
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radiological investigations. These changes in seizure semiology may be due to aberrant 
neural connections caused by axonal sprouting from the excitatory cells as the disease 
progresses
 35,64
. This results in excitatory and inhibitory mismatch causing increased 
excitation leading recurrent firing. 
 
6.2.5. Clustering  
In the present study, we observed a high proportion (41.5%) of patients with 
clustering more than 1-2 times.  Clustering has been reported to be one of the risk factors 
for intractability 
148
. A study by Haut et al. have reported clustering in 29% of their 
subjects out of 141 patients with epilepsy. They reported extratemporal epilepsy and 
head trauma as risk factors for clustering. Increased clustering in the study population 
could be due to extensive involvement of various extratemporal areas in temporal lobe 
epilepsy and longer duration of seizures resulting in an extensive epileptogenic network. 
 
6.2.6. Precipitating factors 
Precipitating factors like sleep deprivation, febrile illness and sleep were 
observed in the study population. Studies with intractable epilepsy do not report 
precipitating factors as risk factors for intractability 
11,12,149,150
. Seizure precipitant among 
400 patients with epilepsy report stress (30%), sleep deprivation (18%), sleep (14%), 
fever or illness (14%), and fatigue (13%) in patients with epilepsy 
151
. In data collection, 
we did not consider stress as one of the precipitating factors. Moreover, one-third of the 
patient with intractable epilepsy was mentally retarded where the data regarding stress 
could not be collected. Similar to the above study we observed sleep deprivation 





6.2.7. Status epilepsy 
The present study investigated the percentage of intractable epilepsy patients who 
had a history of status epilepsy. Status epilepsy being an emergency medical condition 
often associated with clustering and intractability. Status epilepsy is most often reported 
in children with early onset of epilepsy. one study which included 613 children with 
epilepsy, 56 (9.1%) were reported to have one or more episodes of status epilepsy 
152
. 
Another study which recruited 128 patients with status epilepsy, episodes (22.6%) were 
reported to be refractory to first- and second-line antiepileptic treatments 
153
. Similar to 
the above studies, we observed 8.3% of adult intractable epilepsy in the study population 
reported to have had status epilepsy which is lower than expected. This may be due to 
poor maintenance of medical records and poor cognitive status of the patients included in 
the study and also the information regarding status epilepsy collected from the caregivers 
may be inadequate.  
 
6.2.8. Drugs  
As reported by several authors intractable epilepsy patient were often under 
polytherapy 
7,108,133,149,150
. Studies carried out using drug-resistant epilepsy criteria (ILAE 
criteria) report 94% (113/120) of their patients under polytherapy. Similar to the above 
study, in the present study population, 85% of them were under polytherapy. 
 
6.2.9. Co-morbid conditions 
Comorbid conditions like a migraine were observed in 14% of the population 
with intractable epilepsy in the present study. A migraine was reported to be prevalent 
around 26.3%  among 388 patients with epilepsy 
154
. The reduction in the percentage of 
patients with migraine in intractable epilepsy patients could be due to methodological 
differences between the studies where the above study have used International 
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Classification Headache Disorders (ICHD –II) for classifying headaches. The present 
study used reports from the clinical examination on migraine headaches. 
 
6.2.10. Developmental History 
 15% (73/506) of patients with intractable epilepsy in the study had delayed 
developmental milestones. Delay in developmental milestones has been reported in the 
literature as a predictor for intractable epilepsy 
11
. 50 patients with intractable epilepsy 
had MCDs and one-third of patients with intractable epilepsy had a younger age of onset. 
Thus one would expect a high proportion of them have delayed developmental 
milestones. Also, one-third of the patients  with MTS became intractable after an initial 
precipitating injury and latency period. In such a case, less number of patients were 
having congenital malformations affecting developmental milestones in this study. 
Moreover, information provided by the caregivers may be inaccurate and developmental 
records were not available with the patients might have had reduced the percentage of 
patients with delayed developmental milestones. 
 
6.2.11. Family history 
 Family history of seizures was observed only in 6.72% of patients with 
intractable epilepsy. Family history has been reported as a common risk factor for 
intractability in childhood refractory epilepsy 
136,149
. Since only 10% of the study 
population had MCDs, a low frequency of family history of seizures can be expected in 
the present study population. In adult population, family history may not be a significant 
predictor for intractable epilepsy as supported by the study conducted by Tripathi et al 
(2011). The prevalence of family history of seizures in the present study is similar to that 
of the study carried out in Karnataka where they reported a family history of seizure in 






6.2.12. Neurocutaneous markers 
Neurocutaneous markers as reported in several malformations of cortical 
development and syndromes associated with epilepsy were observed in a cohort of 506 
patients with intractable epilepsy. Neurocutaneous markers like adenoma sebaceum, 
neurofibromas, hypomelanosis of ito, and sturge weber syndrome reported 
48,49,136
 to be 
associated with intractable epilepsy had been observed during the study. 
 
6.2.13. Neurological findings 
 19.96% of patients in the study population had headache. The prevalence of a 
postictal headache is similar to the study by Mainieri et al (2015) who report a postictal 
headache in 19.1% of 388 patients with epilepsy 
156
. Also, 3.36% of them had 
hemiparesis following stroke causing intractable epilepsy.  
 
6.3. Structural imaging findings in patients with intractable epilepsy 
6.3.1. CT scan findings 
23.32% of the population in the study showed focal or multiple brain 
abnormalities in CT scan. The present study results revealed an increased percentage of 
CT abnormalities in patients with intractable epilepsy when compared to a study done 
among 905 patients with epilepsy showing CT abnormalities in 13.81% of them 157. This 
study considered CT scan to identify structural lesion like calcifications which were 
reported to be a cause of seizure especially in the Indian subcontinent 
88
. Interestingly in 
the present series of patients, we observed a significant proportion of patients with 
intractable epilepsy having calcifications which are in contrary to the finding in epileptic 
population showing cerebrovascular disorders as major finding in CT scan 
157
. Focal 
cortical –subcortical calcifications 88, focal cortical calcifications 91,158, basal ganglia 
calcifications 
89
, multiple calcifications, calcifications with gliosis and cortical atrophy as 
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reported by several authors were observed in13.43% of the present study population.  
 
6.3.2. MRI findings  
6.3.2.1. Malformations of cortical development  
 9.88% of patients with intractable epilepsy had MCDs. These observations from 
the present study represent that MCDs were observed in higher proportion among 
intractable epilepsy when compared to people with epilepsy. In a cohort of 303 patients 
with epilepsy, Brodtkorb et al 
159
 have reported 4.3% with neuronal migration disorders. 
Li et al 
160
 in 1995 have reported 12% of cortical dysgenesis among a cohort of 341 
patients with chronic refractory epilepsy. A higher proportion (9.88%, n=50) of patients 
with MCD were observed in the present study which is comparable to study carried out 
by Li et al. Difference in the percentage of frequency for MCD could be due to the 
criteria considered (ILAE, 2010) in the present study. 
 
Most common type of MCD in the present study was focal cortical dysplasia 
which constitutes 5.13% of the total population. These results were contrary to the 
studies of Mathew et al 
52 
who report heterotopia as most common cortical malformation 
observed in patients with epilepsy among the Indian population. Though we have 
observed few patients with heterotopia, we observed predominantly focal cortical 
dysplasia as the common malformation in the cohort of 506 intractable epilepsy patients. 
These findings of the present study were supported by a study done by Papayannis et al 
49
 on 3000 adult epilepsy patients who report FCDs as a most common abnormality. 
Many of the patients with focal cortical dysplasia often presented with multiple FCDs 
and hippocampal abnormalities like incomplete hippocampal inversion 
51,54
. Other 
cortical malformations like pachygyria, polymicrogyria, dysembryonic neuroepithelial 
tumor, heterotopia, schizencephaly and hemimegalencephaly were observed in the study 
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as reported by studies done in adults and children in Indian population 
52,136
. Most of the 
patients under focal cortical dysplasia group had seizures during the early developmental 
period. 80% of the patients with malformations of cortical development had partial 
seizures which are considered to be a common finding as reported by studies 
52
 done on 
patients with epilepsy presenting with MCDs (35.3%). These dissimilarities may be due 
to the difference in the patient selection criteria in a specific population. 
 
6.3.2.2. Incomplete hippocampal Inversion  
The present study considered isolated IHI for analysis because it is one of the 
possible structural abnormalities often reported to be associated with temporal lobe 
epilepsy and MCDs 
57
. We analyzed the MRI images of patients with intractable epilepsy 
using 3 selection criteria for IHI. IHI is an atypical anatomical pattern of hippocampus 
often reported to be present in healthy controls 
56,58
 and epileptic population 
57
. There are 
controversies in considering IHI as abnormal in epileptic patients. Studies conducted by 
Bernasconi et al 
57,161
 on MCD and temporal lobe epilepsy have reported that IHI occurs 
in 50% of their population.  In the present study, we observed isolated IHI in 6.92% 
(n=35) among a cohort of 506 patients, which was very low when compared to the 
prevalence of IHI (23%) in 2000 normal population 
162
. This discrepancy could be due to 
the difference in the criteria between the studies for analyzing and identifying IHI. The 
above studies have used several criteria for defining complete and partial IHI whereas we 
have used only 3 criteria for defining IHI. Also, we observed IHI in MCD (40%, n=20) 
population which were excluded from analysis and we considered only isolated IHI 
which might have caused the reduction of its prevalence in intractable epilepsy.  
 
 Similar to the studies that show IHI as a most common finding in left 
hippocampus 
58
, we observed a high proportion of left hippocampal IHI abnormality 
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(30/35) in the present population. Along with MCD and MTS, IHI has been reported to 
occur as an abnormal migration developmental disorder
 57
. Currently, there are no studies 
in the literature about isolated IHI in patients with intractable epilepsy. But in the present 
study, it was observed that a significant amount of population without any abnormality in 
the brain but still showing isolated IHI. This may be interesting to analyze and consider 
IHI as one of the causes for intractability in epilepsy.Histopathological studies and in-
depth imaging with higher resolution MRI in the study population may improve our 
understanding of IHI and its importance in intractability. 
 
6.3.2.3. Mesial temporal lobe sclerosis  
 Mesial temporal lobe sclerosis has been reported by several authors as one of the 
common causes of intractability 
4,18,51,63
. Similarly, in the present study, we observed a 
large population of patients with MTS had intractability that constitute 32.02% (n=162) 
of the total population. A similar study carried out in Singapore 
8
 that has used Drug 
resistant epilepsy (2010) criteria has reported MTS in 32/120 (27%). The present study is 
carried out using the same drug resistant epilepsy criteria on a large population with 
intractable epilepsy showed the slightly high prevalence of MTS in patients with 
intractable epilepsy (i.e in one-third of patients with intractable epilepsy). There are no 
studies in Indian population regarding the prevalence of MTS in intractable epilepsy 
population. The results of the present study emphasize the importance of identifying 
MTS in intractable epilepsy patients who may benefit from surgery 
135,137
.  Also along 
with MTS other lesions like nonspecific gliosis, cystic lesions, MCD, IHI, and infarction 




6.3.2.4. Neoplastic and nonneoplastic lesions (tumors, gliosis, cyst, vascular  
 malformations, inflammation, and infection) 
 Similar to various studies which reported several neoplastic and nonneoplastic lesions as 
a cause for intractable seizures, we observed some of the pathologies in the present population. 
One patient with glioma and another patient with Gliomatosis cerebri having focal epilepsy 
(partial seizure) were observed to be present with intractable epilepsy. Similar tumors 
were reported to be seen in intractable epilepsy in literature 
69
. Also, cortical dysplasia 
and other neuronal migration disorders often coexist with DNET tumors. Similarly, we 
observed one patient with DNET tumor and FCD 
70
. Inflammation and Infections like 
herpes simplex encephalitis with granuloma (1 patient), tuberculous meningoencephalitis 
(2 patients), neurocysticercosis (1 patient) and Hashimoto’s autoimmune encephalitis 





 and tuberous sclerosis 
79
 were also seen. Gliosis at various regions of the 
brain especially parieto occipital and orbitofrontal regions was observed in 29 patients 
(5.70%) with intractable epilepsy signifying nonspecific lesion secondary to trauma, 
ischemia, and inflammation. Changes like gliosis 
84 
were observed in 5.70% of the 
population who might have had trauma, stroke leading to changes in the cell membrane, 
neuronal loss and collateral sprouting causing excitation 
85
. Intractable epilepsy 
associated with infarctions was observed in 12 patients (2.37%).  
 Arteriovenous malformations (AVM) were associated with focal intractable 
epilepsy with secondary generalization in 6 patients (1.18%). All of them had AVM at 
the parietotemporal region.2 patients with intractable epilepsy found to have 
intracerebral hemorrhage (.39%). Most frequently encountered vascular causes of 
intractable epilepsy isarteriovenous malformations (AVMs) and cavernomas 
66
. The 







6.3.2.5. Non-specific lesions  
Idiopathic focal cortical atrophy was observed in 11 patients (2.2%). 
Calcification (focal calcification, multiple calcifications (small and large)), calcification 
with gliosis and calcifications with perilesional edema were observed in 68 patients 
(13.43%). 
 
Focal cortical – subcortical calcifications are reported to be associated with focal 
or generalized epilepsy especially in India. 77.5% of patients with calcifications are 
reported to have focal epilepsy 
88
. Basal ganglia calcifications are often reported to be 
associated with hypoparathyroidism and pseudohypoparathyroidism. Intracranial 
calcifications are also considered as an incidental finding in 0.3 to 1.5% of the patients
 89
.  
Calcification due to infections may be associated with perilesional edema. These patients 
have the tendency to develop seizures intermittently. The pathophysiology of the 
perilesional edema is not clearly understood but it may be due to postictal or release of 
ionic calcium 
90
. Also, focal cerebral calcifications seen in CT scan were found to be 
associated with gliosis around the calcified lesion on T1 weighted MRI images. 33.3% of 
patients with perilesional gliosis is reported to be have increased seizure frequency and 




6.3.3. DTWI findings 
It has been well documented that DTI shows microstructural abnormalities in 
epileptic population (both near the area of abnormality which may be congenital or 
acquired and also away from the seizure loci). Several studies have reported 
microstructural abnormalities in one or several regions among patients with epilepsy 
associated with MCD or MTS
93–103,135
. Similar to these above studies, we found 
microstructural abnormalities in several areas of brain’s white matter that are involved in 
121 
  
intractable epilepsy as described in Table 8. Because diverse abnormalities were 
observed in DTWI we could not classify and group the intractable epilepsy patients into 
subcategories. To simplify the analysis, we classified them into right, left or bilateral 
abnormalities to correlate with other structural imaging techniques. In MTS patients 
were who constitute one-third of the total population were observed abnormal DTI in 
hippocampal and parahippocampal white matter regions along the fimbriae and fornix on 
the same side or on the contralateral side. This shows the involvement of wide neural 
network i.e. medial temporal lobe circuit. 
 
6.4. Neuropsychological assessment in patients with intractable epilepsy 
Several studies have reported significant cognitive impairment and psychological 
illness in epilepsy patients (temporal and extratemporal lobe epilepsy), which were 
accounted due to the disease process (frequency and chronicity) and a side effect of 
antiepileptic drugs
104,106,107,118,121,127,163
. In the present study, we evaluated the 
intelligence, memory, visual perceptual skills, anxiety, depression and quality of life 
among patients with intractable epilepsy.  
 
 Out of 506 patients with intractable epilepsy, 147 patients (29.05%) had mental 
retardation (<69 scores) in Wechsler intelligence scale. Similar studies carried out using 
drug-resistant epilepsy criteria have reported that the 18% of 120 drug-resistant epilepsy 
patients showing mental retardation 
8
. Compared to the above study, we observed 
increased proportion of patients with mental retardation. The results of the present study 
in congruence with the studies (Sayin et al, 2004; Moore et al, 2002) who report 
chronicity (longer seizure duration), early onset of a seizures and recurrent attacks, long-
term antiepileptic drug medication, duration of epilepsy and type of seizure as cause for 
mental retardation
128,129
. All these factors might have caused extensive epileptogenic 
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network leading to significant cognitive impairments.  
Memory impairments are also reported in persons with epilepsy by several 
studies 
12,18,20,96,127,164–166
. In the present study, it was observed that 194 patients (38.34%) 
with significant low scores in Wechsler's memory scores (<70). One-third of patients in 
intractable epilepsy group were mesial temporal lobe epilepsy showed significant 
memory impairments 
18,126,127,167,168
. Other structural abnormalities like MCD, 
calcification, nonspecific lesion in temporal lobe could also impair the intelligence and 
memory scores. From the review of the literature, we could not find a study 
assessing intelligence and memory score among a large number of patients with 
intractable epilepsy using drug-resistant epilepsy criteria. Hence the present study 
would highlight the significant cognitive impairment in intractable epilepsy. 
 
Bender Gestalt test revealed abnormal visuoperceptual gestalt functions in 218 
patients (43.08%) which indicate a significant proportion of patients with intractable 
epilepsy having abnormal visuoperceptual abnormality as reported in the literature 
169,170
. 
Multiphasic personality questionnaire administered to patients without mental retardation 
showed anxiety in 161 patients (31.82%), depression in 142 patients (28.06%) and mixed 
anxiety and depression in 126 patients (24.90%). Similar to the studies on anxiety and 
depression in a person with epilepsy 
114,117,118,171
, the study population also showed 
significant anxiety and depression symptoms. This could be due to temporal lobe 
epilepsy 
172
 which was observed in one-third of the population, frequent epileptic attacks 
and multiple drug interaction 
173,174
. In a large cohort study of 568 patients with epilepsy 
by Kwon and Park, (2013) reported 27.8% with depression and 15.3% with anxiety 
175
. 
When compared to the above study, intractable epilepsy patients had a higher prevalence 
of patients with anxiety and depression.  Univariate and multivariate logistic regression 
in 318 refractory epilepsy patients have shown significant association of 
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pharmacoresistance with depression 
176
. Also, they reported that the underlying 
neurobiological process behind anxiety, depression, and psychosis would increase the 
extent of brain dysfunction and intractability.   
 
Patients who are mentally retarded and dependent had a poor quality of life due 
to severe cognitive dysfunctions. Apart from the patients who had severe mental 
retardation, we could administer WHO Quality Of  Life questionnaire in rest of the 
population. The results revealed that a higher proportion (39%) of patients found to have 
poor quality of life (total quality of life less than 60). Among the domains, social 
relationship (36.17%) was more affected followed by psychological health, environment, 
and physical health domains. The factors that might have contributed to poor quality of 
life could be cognitive deficits
 53,124,167,177





 as reported by several authors in literature.   
 
6.5. Electroencephalography findings  
Interictal EEG in the study population showed generalized abnormalities in 40% 
of the population irrespective of the seizure type.  These findings are similar to the 
reports of EEG in persons with epilepsy often showing generalized abnormalities in a 
greater proportion of patients followed by focal epileptiform discharges 
130
. 15.81% of 
the study population showed focal epileptiform discharges. These findings were 
commonly observed in MTS, focal cortical dysplasia, neoplastic and nonneoplastic 
lesions and nonspecific lesion. Studies with MTS and Focal cortical dysplasia often 
shows focal epileptiform discharges as reported by several authors 
88,130,131,179
. Routine 
interictal EEG were reported to be normal in 40% of patients with epilepsy by several 
authors 
70,130,131,133,134,138,158,179
. When compared to routine EEG, intensive EEG 





.  Similar to the above studies the present study showed a 
significant proportion of patients (43.48%) having normal interictal EEG recordings 
despite intractable epilepsy. 
 
6.6. Association of type of seizure with demographics, clinical characteristics, 
 and neuropsychological findings 
Chi-square test did not show any significant association between the type of 
seizure and other demographic variables like gender, educational level, and occupational 
status.  Clinical characteristics also did not show any association with the type of seizure 
in patients with intractable epilepsy. These findings indicate that intractable epilepsy is a 




Among neurological comorbidities, the postictal headache had an association 
with the type of seizure in the present study. Partial type of seizure had a strong 
association with a headache in 23.31% of the population which was incongruent with the 
study done by Mainieri et al (2015) who reported headache was more common in 
generalized tonic-clonic seizures.  The present study showed a prevalence of a postictal 
headache (19.96%) which is similar to the study by Mainieri et al (2015) who report a 




Seizure semiology change was observed slightly higher (68.02%) in patients with 
partial seizures followed by generalized seizure (56.93%). These seizure semiology 
changes have been reported in both temporal lobe epilepsy patients 
180–182
 and focal 
cortical dysplasias 
51
. In the present study population, 40% of the patients who had 
complex partial seizure were MTS patients. The semiology changes observed in the 
present study could be due to changes due to maturation of brain 
180
, abnormal sprouting 
of axons in the granule cell layer in MTS thereby aberrant neural conduction in the 
epileptogenic network 
18 
and also due to restricted information available on seizure 
125 
  




CT scan findings did not reveal a significant association with both type of 
seizures. 39.02% of patients with partial seizure were significantly associated with MTS 
in MRI. DTWI showed abnormalities in 80.23% of the intractable epilepsy patients. 
These findings were supported by several authors 
93–103,135,137,183
, who showed 
microstructural abnormalities even in the absence of a structural lesion in MRI. DTI 
findings showed the significantly higher proportion of abnormalities in 85.09% of 
patients with complex partial seizures followed by 67.15% of patients with generalized 
seizures. There are no studies in literature that compare types of seizure with DTWI 
findings.  
 
Interictal EEG findings were significantly normal in both CPS and generalized 
seizures. These findings were consistent with several studies using interictal EEG who 
report a low sensitivity of this specific technique in evaluating the seizure types and 
seizure focus 
20,49,138
.   Focal epileptiform discharges were noted in 20.05% of patients 
with partial seizures. Especially these observations were present in patients with MTS 
and FCD. These findings were similar to the reports that state  MTS and FCDs do 
present with focal epileptiform discharges in EEG 
131
.   
 
The present study did not reveal any significant difference between the IQ, MQ, 
BGT, anxiety, depression and quality of life scores between the generalized and partial 
seizure. This could be due to the fact that all patients considered for the study had 
intractable seizures were undergoing polytherapy, longer seizure duration, had early 
seizure onset and increased frequency of seizures which might affect their intelligence, 







6.7. Association of Structural lesions with demographics, clinical characteristics, 
 and neuropsychological findings 
Among structural abnormalities, MTS patients did not differ significantly from 
other structural lesions in demographic and clinical characteristics. This could be because 
irrespective of the focus and type of lesion, intractable epilepsy patients were observed 
with varying age ranges, seizure semiology, clustering, polytherapy, precipitating 
factors, comorbid factors, medical history, family history and EEG. As reported by 
several other authors 
185–192
, the present study showed MTS being more common on the 
left side, followed by the right side and both sides. A similar pattern was observed in 
DTI investigation among MTS patients. 40% of patients with nonspecific lesions showed 
bilateral abnormalities in MRI. 
 
Comparing cognitive impairment among various structural lesions revealed 
significant low IQ, MQ scores BGT abnormalities among MTS patients in intractable 
epilepsy. Neurobiological factors in MTS such as a lesion in the early stage of life 
reduces the brain growth and cognitive development as reported by several authors 
167,193–195
. Also, drug interaction and risk factors during the developmental period have 
been reported to a contributing factor to the cognitive decline in MTS population.  
 
Anxiety and depression were significantly associated with MTS in the present 
study. These findings were supported by the studies which have evaluated anxiety and 
depression in temporal lobe epilepsy 
110
. Hippocampus is an important anatomical 
structure associated with anxiety and depression 
118
, MTS patients often had anxiety and 
depression which may lead to suicidal ideation and poor quality of life 
104,110,114,115,117,118,121,171,176,196,197
.  Quality of life being multidimensional, they are 







6.8. Association of education and occupation with demographics, clinical 
 characteristics, structural lesions and neuropsychological findings 
 Early seizure onset, longer duration of seizures, polytherapy, and low IQ & MQ 
scores 
112,114,145,178,205
 were significantly associated with lower education levels and 
unemployment in intractable epilepsy. Patients without any schooling, elementary or 
high school level of education were associated with unemployment. The unemployment 
rates in intractable epilepsy population were significantly higher when compared to the 
unemployment rates in general population in India
146
. Recurrent attacks of seizure from 
childhood and polytherapy lead to permanent damage to the brain structures particularly 
memory, language and emotional neural network.  This would result in impaired 
cognitive function, learning disability and behavioural disturbances leading to a reduced 
level of education and employment in intractable epilepsy patients 
143,145,178
. Patient who 
have completed high school or graduation were underemployed. Studies that have 
compared education and employment status in intractable epilepsy were sparse in both 
western and Indian population. The present study highlights high percentages of 
patients with intractable epilepsy having cognitive impairment (low IQ -29%, low 
MQ -38%) causing educational underachievement and unemployment in India. 
 
6.9. Localizing side of abnormality across various neuroimaging techniques and 
 EEG 
 CT and MRI could identify the same side of the lesion in more than 80% of 
patients which imply the sensitivity of these neuroradiological investigations to localize 
these lesions. The sensitivity of CT in patients with epilepsy has not been found to be 
higher than 30% in unselected patient populations 
42,90
. The lower sensitivity of CT is 
due to poor resolution of the temporal fossa due to which it is not useful in detecting 
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mesial temporal lobe sclerosis, one of the most common pathologies in refractory 
epilepsy. CT scan may fail to detect abnormalities in up to 50% of patients with 




In intractable epilepsy patients who had normal MRI showed significant DTI 
abnormalities in left and bilateral hemispheres of the brain. Similarly, patient with right 
or left hemisphere abnormalities in MRI lesions showed the same side or bilateral 
hemispheric abnormalities in DTI.  Also, a significant proportion of patients who showed 
bilateral lesions in MRI showed bilateral abnormalities in DTI.  
 
These findings in DTI of the present study are supported by researchers who used 
DTI in epileptic population 
20,93,94,96–103,135,137,183,185–187,189,190,192
 and they reported 
microstructural white matter abnormalities in a significant proportion of patients. In 
temporal lobe epilepsy, we observed same side abnormalities and bilateral abnormalities 
involving the hippocampus, parahippocampus, dentate gyrus, extending to fimbriae and 
fornix. The involvement of the above-mentioned structures reported to be associated 
with white matter abnormalities in temporal lobe epilepsy 
94,95,99,100,103,183,185–192
. In MCD 
population, DTI were useful in evaluating the white matter lesion beyond the lesion site 
101
. In patients with normal MRI results we observed commonly on left-sided or bilateral 




Less proportion of patients with a focal lesion in right or left hemisphere in MRI 
showed similar hemispherical lateralization in interictal EEG 
131,180
. A significant 
association was observed in bilateral lesions in MRI with bilateral abnormalities in EEG 
131,179,182
. Similarly, a significant proportion of patients with bilateral microstructural 
changes in DTWI showed bilateral EEG abnormalities. There are limited numbers of 
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studies with DTI and EEG in patients with intractable epilepsy. This present study 
highlights the extensive involvement of neural network in intractable epilepsy using DTI.  
 
From the present study, it was observed that CT scan is useful in identifying non-
specific lesion like calcifications which is reported in Indian population 
88
.  MRI results 
were more associated MTS and MCDs. Interestingly it was observed that a small group 
of patients (14.42%) who did not have any lesions in CT and MRI but showed 
microstructural abnormalities in DTI
 93,94,95,96,97
. These findings were consistent with 
studies carried out by Dichl et al. (2005), Arfanakis et al. (2002), Gross et al. (2006), 
Tuch et al. (2003). Any one of the neuroimaging techniques is not sufficient to reveal the 
neural network involved in epilepsy. The combination of tests or a test battery approach 
including CT, MRI, DTI and EEG could help us to trace out the structural abnormalities 
in intractable epilepsy. The present study showed 6.13% of intractable epilepsy 
patients did not have any structural abnormalities in the brain using conventional 




















The present study was carried out prospectively to investigate the prevalence, 
demographics, clinical characteristics, psychological status, structural abnormalities, 
EEG and quality of life in patients with intractable epilepsy. From 2850 epilepsy patients 
who were screened using drug-resistant epilepsy criteria, a cohort of 600 patients with 
intractable epilepsy was considered for data collection over a period of 3 years. Out of 
600 patients who have been prospectively followed up only 506 patients with intractable 
epilepsy completed all the investigations. All patients with intractable epilepsy 
underwent detailed case history, neurological examination, CT, MRI and DTI imaging of 
the brain, EEG, and neurological investigations.  
 
 Out of 2850 patients (1523 males and 1327 females) seen at our epilepsy clinic, 
600 (21.05%) patients had drug-resistant epilepsy. The prevalence of intractable epilepsy 
is reported in the study population is estimated to be 21.05 % that approximates 1 in 5 
patients with epilepsy. In the present study, the prevalence of intractable epilepsy was 
observed more in males compared to females possibly due to the patient attending the 
clinics were majorly males compared to females. Analysis on educational and 
occupational status showed that high proportions of patients with intractable epilepsy 
were illiterate (16.8%) and large proportion of them discontinued school at elementary 
level (32.21%) causing high levels of unemployment (37%). Early seizure onset, longer 
duration of seizure, polytherapy, and low IQ and MQ scores  were significantly 
associated with lower education levels and unemployment in intractable epilepsy. 
 
 Clinical characteristics of intractable epilepsy patients were often heterogeneous 
and do correlated with several studies carried out in literature by several authors in 
Indian and Western literature. It was observed that partial type of seizures, younger age 
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of seizure onset, change in seizure semiology, clustering and polytherapy contribute to 
intractability. Interictal EEG studies in intractable epilepsy are highly variable and 
insensitive in providing information regarding the foci of seizure onset. But in 15% of 
the population it is often sensitive to identify seizure foci in focal cortical dysplasia and 
MTS.  
 
Structural imaging investigations revealed various congenital malformations of 
cortical development, mesial temporal sclerosis, neoplastic and nonneoplastic lesions, 
nonspecific lesions and incomplete hippocampal inversion of brain approximately in 
94% of population. Interestingly in the series of  506patients, it was observed that 
significant proportion of patients with intractable epilepsy have calcifications. Diffusion 
tensor weighted images showed significant white matter structural changes in 80% of 
patients which signify DTWI as an important tool to trace the epileptogenic network. 
 
One third of patients (29.05%) with intractable epilepsy were mentally retarded, 
and around 40% of them had significant memory impairments and visuoperceptual 
abnormalities. Cognitive impairments were significantly associated with early age of 
seizure onset, MTS, polytherapy and chronicity of the disease in the study population. 
Also anxiety and depression were associated in one third of intractable epilepsy patients 
who were not mentally retarded.  These populations are high risk for suicidal ideation as 
reported in literature. Quality of life were similarly poor in 40% of the population who 
were not mentally retarded. Thus the present study highlights that cognitive impairment 
and psychological co-morbidities are very common in patients with intractable epilepsy 
which requires necessary action to address these psychological problem by means of 







Though intractable epilepsy patients were studied by neuroimaging and 
electrophysiological (EEG) techniques, they are insensitive in identifying structural 
abnormalities in 6.18% in whom structural abnormalities are still unknown. High 
resolution imaging facilities may help to identify structural lesions in these populations. 
Moreover biochemical and other investigations for metabolic disorders would add an 
additional value in identifying the cause for intractability in patients without any 
structural abnormalities. Intractable epilepsy being a heterogeneous group which is 
difficult to manage, use of modern diagnostic tools may aid in identifying the 
epileptogenic zone and thereby it may help in surgical intervention for the management 




















8.1. Limitations of the study 
 Though intractable epilepsy patients were prospectively studied, the various 
clinical manifestations, structural, electrophysiological and psychological findings in 
patients with intractable epilepsy, it is often difficult to group them into sub-categories. 
This study had tried to include most of the investigations to understand intractable 
epilepsy but still, a few percentage of   them  remained to be a clinical conundrum.  
 
 One of the major limitations of the study is not having a control group of the 
epileptic population to identify the major risk factors in intractability. Though the aim  of 
the present study is not to study the predictors for intractable epilepsy adding a control 






















9.1. Future directions for research  
 
 To investigate for Incomplete Hippocampal Inversion in patients presenting with 
intractable epilepsy after excluding other common causes for intractability  
 To assess role of cerebellum in intractable epilepsy patients using DTI 
 To investigate histopathological abnormalities in MTS and IHI 
 It would be appropriate to investigate the predictors of intractable epilepsy at an early 
age. 
 Among patients who did not show any structural lesions, few of them had metabolic 
encephalopathy (Mitochondrial cytopathy, GLUT 1 deficiency disorder and Lafora 
body disease). Patients whose conventional radio imaging including DTI could not 
demonstrate any structural abnormalities; higher Tesla MRI between 7 to 9 Tesla 

























































 From the present study, it was found that the prevalence of intractable epilepsy in our 
population is 21.05 % using ILAE criteria (2010). 
 The present study revealed 16.8% of illiteracy in adults with intractable epilepsy.  
 The unemployment in patients with intractable epilepsy (36.96%) is significantly 
higher than the unemployment in general population and patients with epilepsy.  
 Partial seizure is the major type of seizure (72.92%) often associated with intractable 
epilepsy. 
 The present study highlights that patients with intractable epilepsy are often 
associated with  neuropsychological manifestations such as cognitive impairment 
(mental retardation -29.05%, memory impairment – 38.34%, abnormal 
visuoperceptual gestalt functions –43.08%),  anxiety (31.82%), depression (28.06%), 
and mixed anxiety-depression (24.90%). 
 It was observed from this study that various structural abnormalities like MTS, 
MCDs, calcification often present with intractable epilepsy. 
 CT investigations could not detect abnormalities in 76% of the population whereas 
MRI could not detect structural abnormalities in 23.52% of the study population. 
MRI is superior to CT in identifying structural lesions in brain. DTWI further 
elucidated 14.42% of structural abnormalities over MRI (who do not show any 
structural lesions). 
 A small percentage of patients (6.13%) did not show any structural abnormalities in 
CT, MRI, DTWI but these patients presented with intractable epilepsy which is still a 
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